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ABSTRACT 
Flaviviruses are arboviruses that can cause neurological disease in mammals. Mice demonstrate 
variable susceptibility to flavivirus disease due to inheritance of a single allele, Flvr. Infected mice 
that possess Flvr exhibit no symptoms and produce less infectious virus compared to mice with the 
susceptible allele Flvs. The product of the Flvr allele, full length 2′-5′ oligoadenylate synthetase 1b 
(Oas1b), is part of the host innate immune response and a Type 1 interferon (IFN) stimulated gene 
(ISG). The Flvr allele encodes a truncated protein due to a premature stop codon. Cells encode 
multiple OAS proteins that exert their antiviral activity by synthesizing short 2′-5′-linked 
oligoadenylates that activate RNase L. Oas1b lacks synthetase activity and function as a dominant 
negative for the active synthetase Oas1a. However, RNase L was shown to have anti-flavivirus 
activity. A line of Oas1b+/+/RNase L-/- mice was generated to analyze the contribution of RNase L 
to the Oas1b-mediated flavivirus disease resistance phenotype in vivo. The results indicated that 
RNase L is a component of the antiviral response to flaviviruses in mice but is not needed for the 
full expression of the Oas1b flavivirus resistance phenotype. 
West Nile Virus (WNV) is a neurotropic virus with strains exhibiting varying degrees of 
pathogenesis in infected humans. The factors involved in this differential pathogenicity are not 
well understood. Using human induced pluripotent stem cells (hiPSCs) differentiated into four 
types of CNS cells, infections with pathogenic WNV NY99 or non-pathogenic WNV MAD78 
were characterized using traditional virology techniques and also by comparative transcriptome 
analysis of infected neural progenitor cells (NPCs) by next generation sequencing. NY99 
replicated efficiently in all four CNS cell types and induced cell cycle arrest in NPCs. 
Transcriptome analysis of astrocytes infected by NY99 revealed robust activation of inflammatory 
response in these cells. MAD78 infected NPCs as efficiently as NY99 but infected astrocytes less 
efficiently than WNV NY99. Infection of astrocytes by both viruses induced secretion of pro-
inflammatory cytokines. Transcriptome analysis of infected NPCs revealed that infections with 
both viruses induced the expression of viral defense genes, ER stress genes, and inhibited neuronal 
development. 
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1 INTRODUCTION 
FLAVIVIRUSES 
Arboviruses are maintained in natural transmission cycles consisting of hemataphageous 
arthropods and vertebrate hosts. Arboviruses of the genus Flavivirus in the family Flaviviridae 
include important human pathogens such as Zika virus (ZIKV), dengue virus (DENV), yellow 
fever virus (YFV) and West Nile virus (WNV) (Lindenbach, Murray et al. 2013). All members of 
the genus Flavivirus have a single-stranded positive sense RNA genome with the same gene 
organization but differ in some of the cis-acting RNA regulatory elements (Brinton 2014). 
Although flaviviruses are primarily found in tropical regions throughout the world, their 
distribution has expanded in the 21st century due to broadening mosquito ranges, to increases in 
human population density, and to increases in worldwide travel (Lindenbach, Murray et al. 2013).  
West Nile virus was first isolated in Uganda in the early twentieth century (Suthar, 
Diamond et al. 2013). WNV is spread by mosquitoes and is maintained in nature via a transmission 
cycle between small birds and mosquitoes with humans and horses as dead-end hosts. Sequence 
analysis of the genomes of WNV isolates has revealed two main lineages. Lineage 1 viruses are 
found throughout the world including in the Americas, the Middle East, Europe, India and 
Australia (Lanciotti, Ebel et al. 2002). Lineage 2 viruses are primarily found in Africa but recent 
evidence suggests that some of these viruses have spread to Europe (Erdelyi, Ursu et al. 2007).  
While most outbreaks of disease in humans were due to lineage 1 viruses, both lineages include 
pathogenic and non-pathogenic members (Brinton 2014). WNV infection in humans typically 
causes no symptoms or a mild febrile illness but can occasionally cause serious neurological 
pathology (Lindenbach, Murray et al. 2013). The Centers for Disease Control and Prevention 
(CDC) reported in 2012 that there were 5,674 documented cases of WNV disease with 51% 
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causing neuroinvasive disease and a mortality rate of 5%. The actual number of WNV infected 
individuals is likely higher due to either lack of symptoms or non-reporting of symptoms (Centers 
for Disease and Prevention 2013). There is emerging evidence that resolution of WNV infection 
of the CNS may have prolonged negative effects on neurological health (Garber, Vasek et al. 
2018). 
WNV PATHOGENESIS IN HUMANS 
WNV replicates in the midgut cells and salivary glands of Culex mosquitoes and is spread 
to other hosts during mosquito feeding. In humans, the virus initially replicates in cells of the 
epidermis including antigen-presenting Langerhans cells (Suthar, Diamond et al. 2013). Infected 
Langerhans cells can migrate to draining lymph nodes, facilitating spread of the virus to the lymph 
nodes, then to the blood, and then to organs including the spleen, liver, and kidneys (Johnston, 
Halliday et al. 2000). In some humans infected with some strains of WNV, the virus crosses the 
blood-brain barrier (BBB) and enters the central nervous system (CNS). The BBB is comprised of 
the endothelial cells which line the blood vessels in the brain and foot processes of astrocytes 
which wrap around the blood vessels and form tight junctions to prevent free movement of 
molecules into the CNS (Daneman and Prat 2015). The factors involved in neuroinvasion by some 
strains of WNV and not others are not well understood (Hussmann, Samuel et al. 2013, Suthar, 
Diamond et al. 2013). Once in the CNS, neurons appear to be the primary targets of WNV 
infection. Cell death occurs through caspase 3-dependent apoptosis (Samuel, Morrey et al. 2007). 
Neurons are classified into several different subtypes based on their location and function in the 
brain. The ability of viruses to infect these different neuron subtypes can have a large impact on 
inflammation in the CNS due to differing activation of and sensitivity to host antiviral defense 
responses (Cho, Proll et al. 2013). Infected neurons express CXCL10 and other pro-inflammatory 
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cytokines that result in recruitment of T cells and other infiltrating cells to the CNS and may also 
facilitate the BBB becoming leaky through the activity of matrix metalloproteinases (Samuel and 
Diamond 2009). CNS cells infected with WNV demonstrate endoplasmic reticulum (ER) stress 
that can lead to apoptosis through activation of the unfolded protein response (UPR) (Medigeshi, 
Lancaster et al. 2007). Glial cells such as astrocytes can become activated following CNS 
infection, leading to secretion of pro-inflammatory cytokines such as TNF-α and IL-6 (Cho and 
Diamond 2012). 
WNV LIFE CYCLE 
WNV virions are 50 nm in diameter and have an envelope membrane that contains the viral 
envelope (E) protein and membrane (M) proteins. The E proteins form head-to-tail homodimers 
that lie flat against the membrane and form a smooth quasi-icosahedral shell. The nucleocapsid is 
composed of capsid (C) protein dimers that have hydrophobic regions for interaction with the 
cytoplasmic face of the ER membrane and charged regions that likely interact with the viral RNA 
(Lindenbach, Murray et al. 2013). In culture, WNV can infect primary cells and cell lines from 
many different host species, including mammalian, avian, and insects. The viral E protein attaches 
to an unknown receptor at the cell surface and virions in clathrin-coated pits enter the cell via the 
endosomal pathway (Brinton 2014). The increasing acidity of early endosomes triggers a 
conformational rearrangement of the E protein that mediates fusion of the virion membrane with 
the cell endosomal membrane. This facilitates release of the viral genome into the cytoplasm 
(Lindenbach, Murray et al. 2013). Flavivirus genomes are single stranded RNA (ssRNA) of about 
11 kb in length with a 5′ cap but no 3′ poly(A) tail. The viral genome acts as a messenger RNA 
(mRNA). It contains a single open reading frame (ORF) that can immediately be used to translate 
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the viral polyprotein. The viral polyprotein is cleaved by viral and host proteases into 3 structural 
and 7 non-structural proteins (Brinton 2014).  
Translation of the viral polyprotein from the genomic RNA occurs in the cytoplasm of the 
infected cell. The efficiency of viral protein translation appears to be a major determinant of 
virulence, yet the mechanisms of viral translation outcompeting cellular translation are poorly 
understood (Edgil, Diamond et al. 2003). Mosquito-borne flaviviruses utilize cap-dependent 
translation but have been shown to be able to use cap-independent methods as well (Edgil, Polacek 
et al. 2006, Villas-Boas, Conceicao et al. 2009, Perez Dominguez, Rojas et al. 2015). Despite not 
having a poly(A) tail, the 3′-NCR of a mosquito-borne flavivirus genomic RNA can bind poly(A)-
binding protein (PABP). This interaction may enhance cap-dependent translation of the viral 
polyprotein through facilitating interaction of the 3′ end of the genome with the 5′ cap binding 
proteins (Polacek, Friebe et al. 2009). The viral structural proteins C, E and M are encoded in the 
5′-end of the genome while the nonstructural proteins NS1, NS2A, NS2B, NS3, NS4A, NS4B and 
NS5 are encoded in the 3′ region (Lindenbach, Murray et al. 2013). The viral polyprotein is cleaved 
to the mature proteins by the viral protease complex, NS2B-NS3, and by the activity of cellular 
proteases. The viral non-structural proteins are all required for viral RNA replication and also have 
additional functions in the cell during infection (Brinton 2014).  
The coding region of a flavivirus genome is flanked by non-coding regions (NCRs) that 
contain several cis-acting secondary structural elements. Cyclization sequences (CYC) and 
flanking sequences in the 3′ and 5′ NCRs are essential for the long-distance RNA-RNA interactions 
that regulate the switch from viral protein translation to negative sense (-)RNA synthesis 
(Khromykh, Meka et al. 2001, Lo, Tilgner et al. 2003). The NCRs can also bind to host proteins 
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that are important for viral replication and protect viral genomes from digestion by 
exoribonucleases (Lindenbach, Murray et al. 2013).  
Flavivirus RNA replication is semiconservative and asymmetric. Following cyclization of 
the genome, a single complementary (-)RNA is synthesized from the genome that then serves as 
the template for the synthesis of new genomes. In infected cells, the viral RNA is primarily found 
in three distinct forms: single-stranded plus strand (+)RNA, double stranded RNA (dsRNA) 
replicative form consisting of a positive and negative strand RNA and replicative intermediate (RI) 
RNA made up of a (-)RNA strand and multiple (+)RNA strands.  Early in the replication cycle, 
the amount of minus and plus strand RNA is approximately equal but at later times more than a 
10-fold accumulation of plus strand over minus strand is detected in infected cells (Brinton 2014). 
Viral genomes are replicated by replication complexes (RCs) formed by all of the viral 
nonstructural proteins. Substantial cytoplasmic membrane proliferation and rearrangement occurs 
in infected cells and convoluted membranes (CM) are concentrated around the nucleus in areas of 
viral RNA replication. At early times post infection the reinitiation of (+)RNA strand synthesis 
from the (-)RNA template is inefficient. At later times post infection, (+)RNA synthesis becomes 
very efficient and nascent viral genomic RNA is produced at an exponential rate (Brinton 2014). 
The switch to exponential (+)RNA transcription coincides with the appearance of invaginations of 
the endoplasmic reticulum (ER) called replication vesicles (RV) that contain the RC and viral 
dsRNA. Newly synthesized (+)RNA strands exit these RVs into the cytoplasm through a small 
pore and are either translated, transcribed to make new (-)RNA templates or are assembled into 
virions  (Welsch, Miller et al. 2009, Brinton 2014). 
The exact mechanism of viral genomic RNA encapsidation is not well understood but it 
appears that interaction of genomic RNA with C proteins that line the cytoplasmic face of the ER 
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in areas that contain preM and E leads to viral progeny budding into the ER lumen (Welsch, Miller 
et al. 2009, Brinton 2014). The preM and E proteins extend into the ER lumen as heterodimers that 
associate into trimers. The preM protein assists with proper folding of the E protein and prevents 
premature acid-catalyzed rearrangement of the E protein (Mukhopadhyay, Kuhn et al. 2005). 
Immature virions accumulate in the ER lumen and are transported through the Golgi apparatus 
(Welsch, Miller et al. 2009). As part of virus maturation the cell protease furin cleaves preM to M, 
which then allows the E proteins to undergo a conformational change to form head to tail 
homodimers that lie flat against the viral envelope (Lindenbach, Murray et al. 2013). Mature 
virions are exocytosed at the plasma membrane. Progeny virus can be detected exiting an infected 
cell by 8 to 10 hours after infection (Brinton 2014).  
FLAVIVIRUS NONSTRUCTURAL PROTEINS 
The nonstructural proteins NS2A, NS2B, NS4A and NS4B each contain multiple 
membrane-spanning domains that anchor them in the ER membrane. NS2A is a 20 kD 
hydrophobic protein that is located in the RVs where it interacts with NS3, NS5, the 3′-NCR of 
the genome and also has been shown to play a role in virus assembly (Lindenbach, Murray et al. 
2013). In human cells dengue virus and WNV NS2A can antagonize Type I interferon (IFN) 
signaling by inhibiting signal transducers and activators of transcription 1 (STAT1) 
phosphorylation in the JAK/STAT signaling pathway and blocking IFN stimulated gene (ISG) 
induction (Cumberworth, Clark et al. 2017). It may also contribute to IFN-independent apoptosis 
and virulence in mice (Melian, Edmonds et al. 2013). NS2B is a co-factor for the NS3 protease 
and is essential for viral protease activity (Erbel, Schiering et al. 2006). 
NS4A and NS4B are small (16 kDa and 27 kDa, respectively) hydrophobic proteins that 
are connected by a 2K linker. Both proteins colocalize with dsRNA and NS3 in infected cells, 
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indicating that they are in the RVs (Lindenbach, Murray et al. 2013). Expression of NS4A-2K 
alone or coexpression of NS4A-2K-NS4B together with the NS2B-NS3 protease induced 
cytoplasmic membrane rearrangement in mammalian cells (Roosendaal, Westaway et al. 2006). 
NS4A and NS4B from mosquito-borne flaviviruses can block the Type 1 IFN response at multiple 
steps in the pathway following 2K cleavage. Of the two, the Type 1 IFN-antagonist activity of 
NS4B appears to be more robust and more highly conserved (Chen, Wu et al. 2017). 
NS1 is a 46 kDa glycoprotein found associated with RCs in the ER lumen of infected cells 
and also at the plasma membrane (Lindenbach, Murray et al. 2013). NS1 is hydrophilic but in cells 
it can form homodimers that have an affinity for membranes. The N-glycosylation residues in NS1 
have been shown to be crucial for RNA replication (Brinton 2014). RNA replication deficient 
mutants of YFV with large deletions in NS1 were able to replicate viral RNA when NS1 was 
supplied in trans, indicating that it may function in the initiation of viral RNA replication 
(Khromykh, Sedlak et al. 1999). NS1 is secreted from infected cells as hexamers starting at 16 
hours post infection (hpi) and protects virions by antagonizing the complement anti-microbial 
pathway. (Brinton 2014). NS1 directly interacts with complement components H, C1 and C4, and 
these interactions are facilitated by glycosylation at several key residues on the protein. Mutation 
of these residues has little effect on viral replication in mammalian cell cultures but dramatically 
decreases neuroinvasiveness, neurovirulence and viremia in mice (Whiteman, Li et al. 2010). 
NS3 is a 70 kDa protein with a wide range of important functions. The N-terminal region 
is a serine protease that requires NS2B as a co-factor. This viral protease cleaves the polyprotein 
at adjacent basic residue sites at the NS2A/NS2B, NS2B/NS3, NS3/NS4A and NS4B/NS5 
junctions and cleaves at the C-terminus of the C protein (Lindenbach, Murray et al. 2013). 
Membrane association is required for protease activity and is likely facilitated through interaction 
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with the membrane bound NS2B. The C-terminal region of NS3 has helicase, nucleoside 
triphosphatase (NTPase), and RNA 5′-triphosphatase (RTPase) activities that are all stimulated by 
the presence of RNA (Brinton 2014). A highly conserved Walker B motif found in the helicase 
domain is crucial for all three of these functions (Benarroch, Selisko et al. 2004). After binding to 
ssRNA, the NS3 protein undergoes a conformational change that facilitates ATP hydrolysis to 
drive helicase activity (Brinton 2014). Interestingly, DENV NS3 can anneal complementary RNA 
strands in the absence of ATP, suggesting that the concentration of ATP may serve a regulatory 
role for NS3 switching between annealing and unwinding of the viral RNA (Gebhard, Kaufman et 
al. 2012). NS4A is a co-factor for helicase activity (Shiryaev, Chernov et al. 2009). NS3 RTPase 
activity is non-specific and can act on any 5′ RNA terminus. This activity is a necessary first step 
for 5′-capping of the viral genome. The expression of NS3 alone can induce caspase-8-dependent 
apoptosis in cells (Lindenbach, Murray et al. 2013).  
NS5 is a large 103 kDa protein that is the most conserved of all the flavivirus proteins. Its 
N-terminal domain has guanyltransferase and methyltransferase (MTase) activities. NS5 performs 
N-7 methylation and 2′-O methylation of the viral genome RNA 5′-terminus in conjunction with 
NS3 RTPase activity (Brinton 2014). Both the N7 and 2′-O MTase activities of NS5 are necessary 
for virus replication and innate immune evasion (Lindenbach, Murray et al. 2013). The C-terminal 
domain of NS5 has conserved RNA-dependent RNA polymerase (RdRp) motifs that are found in 
the polymerases of many plus strand RNA viruses. In vitro RdRp activity has been demonstrated 
for purified NS5 from WNV, JEV and DENV (Lindenbach, Murray et al. 2013). Mutation of the 
highly conserved GDD sequence ablates WNV NS5 RdRp activity (Guyatt, Westaway et al. 2001). 
Characterization of the DENV NS5 RdRp activity revealed that genome cyclization due to the 
presence of both CYC sequences was necessary for de novo initiation of (-)RNA synthesis 
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although RNAs with complementary mutant 3′ and 5′ CYC sequences also worked as templates 
(Ackermann and Padmanabhan 2001). Despite the critical role of NS5 in RNA replication, some 
NS5 translocates to the nucleus due to having two functional nuclear localization signals. In the 
nucleus it likely plays a role in antagonizing the innate immune response in infected cells (Best, 
Morris et al. 2005, Pryor, Rawlinson et al. 2007, Ye, Chen et al. 2017).  
CELLULAR INNATE IMMUNE RESPONSE TO A VIRUS INFECTION 
 Mammalian cells counteract viral infection in neurons and other cells through the activity 
of Type 1 IFNs (Samuel and Diamond 2005). IFN expression is activated following detection of 
pathogen associated molecular patterns (PAMPs) by host cell pattern recognition receptors (PRRs) 
found at the plasma membrane, in endosomal compartments and in the cytoplasm (Suthar, Aguirre 
et al. 2013). TLRs found in endosomes can detect both ssRNA and dsRNA from incoming viruses 
(Kawai and Akira 2007). Retinoic acid inducible gene I (RIG-I)-like receptors (RLRs) are found 
in the cytoplasm and detect dsRNA such as viral replicative intermediates or secondary RNA 
structures (Loo, Fornek et al. 2008). Following PRR binding to PAMPs, downstream effectors 
activate transcription factors, including IFN regulatory factor (IRF) -3 and -7 and nuclear factor 
kappa B (NF-κB), that leads to production and secretion of Type I IFNs. Secreted Type I IFNs 
bind to the IFNα/β receptor complex (IFNAR) and activate tyrosine kinase 2 (TYK2) and Janus 
kinase 1 (JAK1) to phosphorylate STAT proteins. Phosphorylated STAT-1 and STAT-2 form a 
complex with IRF-9 that translocates to the nucleus and binds to interferon-stimulated response 
elements (ISREs) in the promoters of ISGs, activating their expression and creating an antiviral 
state (Suthar, Diamond et al. 2013). The activities of several ISGs have been implicated in 
contributing to survival of a flavivirus infection by mice (Samuel, Whitby et al. 2006). 
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INHERITED FLAVIVIRUS DISEASE RESISTANCE  
 Mice with a single autosomal dominant allele (Flvr) are resistant to lethal doses of 
flavivirus after intracerebral (IC), subcutaneous (SC), or intraperitoneal (IP) inoculation. This 
resistance does not extend to viruses outside of the genus Flavivirus. Flvr mice are susceptible to 
infection by flaviviruses but develop no detectable symptoms (Shellam, Sangster et al. 1998). Flvr 
mice produce lower titers of virus than susceptible mice (Flvs) indicating that virus replication is 
suppressed (Brinton, Arnheiter et al. 1982, Urosevic, van Maanen et al. 1997). Mouse embryonic 
fibroblasts (MEFs) derived from Flvr mice also produce lower yields of virus than those from Flvs 
mice, although the difference in titer is less dramatic than in mice (Brinton, Arnheiter et al. 1982). 
The resistance phenotype demonstrates an autosomal dominant mode of inheritance. Congenic 
mice homozygous for Flvr (C3H/RV) were generated from susceptible mice (C3H/He) by breeding 
C3H/He mice with the resistant PRI strain followed by 9 rounds of backcrossing progeny to 
C3H/He mice and then selecting the progeny for further breeding at each round by screening for 
flavivirus disease resistance (Brinton and Perelygin 2003).  
OAS1B-MEDIATED FLAVIVIRUS DISEASE RESISTANCE 
 The Flvr phenotype is conferred by a single gene, 2′,5′-oligoadenylate synthetase (OAS) 
1b (Oas1b) (Perelygin, Scherbik et al. 2002). Due to the presence of a premature stop codon, the 
product of the susceptible allele of Oas1b (Oas1bt) is missing the C-terminal region that contains 
a transmembrane domain. Using a homologous recombination strategy, the C-terminal sequence 
from a resistant mouse was knocked into the susceptible allele in C57BL/6 mice and the 
homozygous Oas1b-KI  mouse strain was generated. These mice are resistant to flavivirus-induced 
disease (Scherbik, Kluetzman et al. 2007).  
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THE OAS/RNASE L PATHWAY 
 Oas1b is an ISG and a member of the OAS family of host antiviral proteins (Kakuta, 
Shibata et al. 2002). Humans have OAS1, OAS2, OAS3 and OASL genes. Mice, in addition to 
having OAS2 and OAS3 and two copies of OASL, have eight Oas1 genes (Oas1a-Oas1h). OAS 
proteins detect incoming pathogens such as viruses by sensing dsRNA (Donovan, Dufner et al. 
2013). Upon activation, OAS proteins polymerize ATP generating short 2′-5′ linked 
oligoadenylates (2-5A) that activate the cytosolic endoribonuclease RNase L. RNase L then non-
specifically degrades single-stranded RNAs, including viral RNAs (Silverman 2007).  
 The canonical OAS/RNase L pathway has an antiviral effect on flavivirus replication but 
it is not as robust as the inhibitory effect of Oas1b (Scherbik, Paranjape et al. 2006). Oas1b is an 
inactive synthetase that has also been shown to inhibit Oas1a 2-5A production in vitro and in vivo 
by acting as a dominant negative (Elbahesh, Jha et al. 2011). This dominant negative effect would 
be expected to increase rather than decrease virus yield. However, while infected resistant MEFs 
expressing a dominant negative form of RNase L showed some increase in virus yield, the levels 
were still lower than those in susceptible cells with RNase L activity unimpeded (Scherbik, 
Paranjape et al. 2006). The flavivirus specific nature of Oas1b-mediated viral inhibition may in 
part be due to its transmembrane domain which was shown to target it to the ER where the (+)RNA 
producing RVs are located. The susceptible Oas1bt is C-terminally truncated and lacks the 
transmembrane domain (Courtney, Di et al. 2012). The flavivirus inhibitory activity also appears 
to be mediated by its two binding partners, ATP-binding cassette subfamily f member 3 (ABCF3) 
and oxysterol binding protein-related protein 1L (Orp1L) (Courtney, Di et al. 2012).  
 ABC genes are a large family of conserved transporter proteins. They have a conserved 
ATP-binding domain made up of Walker A and Walker B motifs and also a third motif, C, that is 
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unique to ABC proteins (Schriml and Dean 2000). The precise functions of ABCF3 in mammalian 
cells are not known. ABCF3 interacts with Oas1b, Oas1bt and a mutant form of Oas1b that was 
missing only its transmembrane domain (Oas1bΔTM). RNAi-mediated reduction of ABCF3 levels 
in cells resulted in increased production of WNV in resistant MEFs but had no effect on the 
replication of other types of RNA viruses or on WNV replication in susceptible MEFs (Courtney, 
Di et al. 2012). 
 Orp1L is a cholesterol-sensing protein that is involved in targeting late endosomes to the 
ER membrane and regulates cholesterol transport from late endosomes/lysosomes to the ER 
(Rocha, Kuijl et al. 2009, Zhao and Ridgway 2017). Knockdown of Orp1L decreased flavivirus 
production in Oas1b+/+ MEFs, but this result was not specific to flaviviruses, and was believed to 
be due to the involvement of Orp1L in the regulation of endosomes, which are required for virus 
entry. Orp1L did not interact with Oas1bt but did interact with Oas1bΔTM indicating that its 
interaction region is located between the end of Oas1bt and the beginning of the transmembrane 
domain (Courtney, Di et al. 2012). 
 
GOALS OF THIS DISSERTATION 
Specific Aim 1: Characterization of components of the Oas1b-mediated flavivirus disease 
resistance phenotype in mice 
 Flavivirus disease resistance in mice is due to inheritance of the Flvr allele, which encodes 
Oas1b, a full length, inactive 2-5A synthetase that has a dominant negative effect on an active 
Oas1 synthetase, Oas1a (Elbahesh, Jha et al. 2011). RNase L, the 2-5A downstream effector, is an 
endonuclease that cleaves cell and viral ssRNA. Oas1b is one member of a family of OAS proteins. 
OAS protein expression is upregulated by Type 1 IFN signaling, which is activated by a flavivirus 
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infection. Previous studies showed that RNase L has anti-flavivirus activity and that It can cleave 
flavivirus genome RNA. Whether RNase L activity contributes to the flavivirus resistance 
phenotype in mice will be analyzed and the characteristics of this resistance phenotype will be 
further investigated. 
Specific Aim 2: Characterization of the response of human induced pluripotent stem cell-
derived CNS cells to infection with pathogenic and nonpathogenic strains of WNV. 
 The majority of infections with WNV in humans are asymptomatic but occasionally WNV 
infection can cause serious CNS disease with the potential for long term complications following 
resolution of the infection (Winkelmann, Luo et al. 2016). Comparison of the differential response 
of pathogenic and nonpathogenic strains of WNV in different types of human CNS cells may 
provide insight into the molecular mechanisms involved in WNV encephalitic disease induction 
and outcome. The responses to pathogenic WNV strain NY99 and the nonpathogenic WNV strain 
MAD78 infections of human induced pluripotent stem cells (hiPSCs) differentiated into neural 
progenitor cells (NPCs) and of NPCs differentiated into neurons or astrocytes will be analyzed. 
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2 SPECIFC AIM 1: CHARACTERIZATION OF OAS1B MEDIATED DISEASE 
FLAVIVIRUS DISEASE RESISTANCE IN MICE 
INTRODUCTION 
 The genus Flavivirus in the family Flaviviridae, includes West Nile virus (WNV), dengue 
virus, yellow fever virus (YFV) and Zika virus (ZIKV). These are mosquito-borne, zoonotic 
pathogens that typically induce no symptoms or a mild febrile illness in infected humans but can 
cause serious neurological pathology (Lindenbach, Murray et al. 2013). A genetically controlled 
resistance phenotype that is specific for members of the genus Flavivirus was previously 
discovered in mice. Resistance is conferred by a single, autosomal, dominant allele of the Flv locus 
(Flvr) (Shellam, Sangster et al. 1998, Brinton and Perelygin 2003). Flvr mice are permissive to 
infection by flaviviruses but produce lower virus titers and do not develop symptoms after 
infection with doses of flavivirus that cause disease and death in animals that are homozygous for 
the susceptible allele (Flvs). The Flv locus was subsequently identified as the Oas1b gene 
(Perelygin, Scherbik et al. 2002). The mRNA for the susceptibility allele of the Oas1b gene 
contains a premature stop codon and produces a truncated protein (Oas1bt) that lacks the C-
terminal transmembrane domain. The C-terminal region of the Oas1b resistance allele was 
knocked into the susceptible allele in C57BL/6 mice using a homologous recombination strategy 
and a line of homozygous C57BL/6 Oas1b+/+ mice were then bred (Scherbik, Kluetzman et al. 
2007). These mice are fully resistant to flavivirus-induced disease, confirming that expression of 
the full length Oas1b protein is necessary for the resistance phenotype.  
 Oas1b is a member of the OAS gene family and OAS genes are interferon stimulated genes 
(ISGs) (Kakuta, Shibata et al. 2002). The human genome encodes single copies of the OAS1, 
OAS2, OAS3 and OASL genes. In contrast, the mouse genome contains single copies of Oas2 and 
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Oas3, two copies of OasL, and eight copies of Oas1 (Oas1a-Oas1h). Only the mouse Oas1a and 
Oas1g proteins have 2′, 5′-oligoadenylate synthetase enzymatic activity (Elbahesh, Jha et al. 2011, 
Elkhateeb, Tag-El-Din-Hassan et al. 2016). OAS proteins are activated by dsRNA and therefore 
detect virus infections in infected cells (Donovan, Dufner et al. 2013). Upon activation, OAS 
proteins polymerize ATP and generate short 2′-5′ linked oligoadenylates that activate cytosolic 
endoribonuclease RNase L. RNase L dimerizes and then non-specifically degrades single-stranded 
RNAs, including viral RNAs (Silverman 2007). RNase L was previously shown to have antiviral 
activity against flaviviruses. WNV genomic RNA is susceptible to cleavage by RNase L and 
C57Bl/6RNase L-/- MEF cell lines had 5 to 10 times higher WNV yields compared to C57BL/6 
cell lines (Scherbik, Paranjape et al. 2006). Samuel et al. (Samuel, Whitby et al. 2006) found that 
only 10% of C57BL/6 mice lacking PKR and RNase L survived WNV infection compared to 70% 
survival of WT C57BL/6 mice. Oas1b is an inactive synthetase and also has a dominant negative 
effect on 2-5A production by an active Oas1 synthetase (Elbahesh, Jha et al. 2011). 
 The C-terminal domain of Oas1b targets it to the ER membrane in cells. Viral RNA 
replication occurs within viral protein-induced invaginations within the ER membrane. The 
localization of Oas1b to these invaginations could be related to its anti-flavivirus action. A yeast 
two-hybrid screen identified two putative cellular Oas1b binding partners: ATP-binding cassette 
3, subfamily f (ABCF3) and oxysterol binding protein-related protein 1L (Orp1L) (Courtney, Di 
et al. 2012). ABCF3 interacted with both Oas1b and Oas1bt whereas Orp1L only interacted with 
the full-length protein. The transmembrane domain of Oas1b was not necessary for the Orp1L 
interaction. A knockdown of ABCF3 resulted in increased flavivirus specific replication in 
resistant MEFs and overexpression of ABCF3 increased the flavivirus-specific inhibition of virus 
replication in resistant MEFs. Knockdown of Orp1L in resistant MEFs caused decreased viral 
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replication that was not specific to flaviviruses. Orp1L is a regulator of endosomes and it is likely 
that the observed effect was on virus entry and due to dysregulation of the endosomal pathway 
(Courtney, Di et al. 2012). The specific roles of these partners in the flavivirus-specific inhibition 
mechanism mediated by Oas1b is not known.  
 To analyze the contribution of the antiviral activity of RNase L to the flavivirus resistance 
phenotype in resistant mice, Oas1b+/+ mice were bred with RNase L-/- mice to generate 
Oas1b+/+/RNase L-/- animals and flavivirus infection in these animals was characterized. Resistant 
mice deficient for RNase L were fully resistant to flavivirus-induced disease and demonstrated 
decreased viral yields and levels of viral genomic RNA compared to susceptible mice with and 
without RNase L. Susceptible RNase L-/- mice demonstrated increased viral titers compared to 
RNase L+/+ mice, confirming the anti-WNV activity of RNase L. Consistent with the lower viral 
titers in resistant mice, the Type 1 IFN response was upregulated to a lower level in the resistant 
mice compared to the susceptible mice. 
 
MATERIALS AND METHODS 
Generation of an Oas1b+/+/RNase L-/- mouse strain.  
All animal work was done in accordance with approved IACUC protocols. Two C57BL/6 breeding 
pairs were obtained from Jackson Labs and used to initiate a colony at Georgia State University. 
C57BL/6 mice are homozygous for the susceptibility allele of the Oas1b gene (produce Oas1btr). 
Previously, a new strain of flavivirus resistant mice C57BL/6 Oas1b+/+ was generated by knocking 
in the resistant allele from C3H.PRI-Flvr mice into the C57BL/6 genome using a homologous 
recombination strategy (Scherbik, Kluetzman et al. 2007). C57BL/6 mice which are homozygous 
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for RNase L knockout (C57BL/6 RNase L-/-) were obtained from Dr. Robert Silverman (Cleveland 
Clinic). C57BL/6 Oas1b+/+ mice were bred to C57BL/6 RNase L-/- mice. The F1 progeny were 
then bred. The F2 progeny were genotyped for each allele of interest by southern blotting as 
previously described (Scherbik, Kluetzman et al. 2007). Animals homozygous for both the 
resistant Oas1b and RNase L-/- alleles were used as breeders to establish a colony of C57BL/6 
Oas1b+/+/RNase L-/- mice.  
 
Cells and viruses.  
Baby hamster kidney 21/W12 (BHK) cells were maintained in minimal essential medium (MEM) 
with 2.5% heat-inactivated fetal bovine serum (FBS) and 10 µg/ml gentamicin at 37˚C and 5% 
CO2 (Courtney, Di et al. 2012).  
YFV-17D lyophilized vaccine (Wyeth Laboratories) was reconstituted in sterile PBS according to 
the manufacturer’s instructions. The virus titer was 4x106PFU/ml. An aliquot of WNV strain NY99 
was obtained from Dr. Robert Tesh at the World Reference Center for Emerging Viruses and 
Arboviruses, University of Texas Medical Branch. A virus stock was prepared by infecting 
confluent BHK monolayers at a MOI of 0.1. The culture fluid was harvested at 42 hours post 
infection (hpi), clarified by low speed centrifugation, aliquoted and stored at -80˚C. The titer of 
this stock was 6.5x106PFU/ml. The infectivity of both YFV and WNV samples was determined 
by plaque assay on BHK cells as previously described (Courtney, Di et al. 2012). Briefly, virus 
was serially diluted in MEM supplemented with 2.5% FBS and adsorbed on confluent BHK 
monolayers for 1 hr at 37˚C. After the incubation period, the virus inoculum was aspirated and the 
cells were washed with Hank’s balanced salt solution (HBSS) and then overlaid with 2 ml/well of 
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1% SeaChem (Bio-Whittaker Molecular Applications) agarose mixed 1:1 with 2X MEM 
containing 5% fetal calf serum. The cells were incubated at 37˚C for 72 hpi then stained using 
0.05% crystal violet in 10% ethanol. All samples were assayed in duplicate.  
 
Mouse infection protocols.  
Groups of 6 to 8 week old mice were anesthetized using 2% isoflurane until a surgical plane was 
reached. The mice were then injected by the intracerebral (IC) route using a 26½ gauge needle 
fitted with a plastic guard with 500 PFU of YFV-17D or with 100 PFU of NY99 in 0.01 ml of 
sterile PBS.  
For in vivo virus susceptibility experiments, following IC virus inoculation, mice were initially 
observed once daily for the development of signs of encephalitis and then twice daily when signs 
appeared. The posture, grooming behavior, and presence of limb paralysis were assessed to 
determine disease severity. Animals demonstrating hindlimb paralysis were assessed to be 
moribund, euthanized and counted as having died the next day.  
 
Analysis of infectious virus, viral RNA and ISG mRNA levels in the brains of infected mice.  
On different days following virus inoculation, groups of mice were sacrificed every day starting 
on day two. Mice were deeply anesthetized with isoflurane. Once at a surgical plane, the mice 
were decapitated and the brains aseptically removed. The brains were cut in half on the sagittal 
plane using a sterile razor blade. Each half was weighed and stored at -80˚C. To make brain tissue 
homogenate, one half was of each brain placed into a dounce homogenizer on ice and the correct 
amount of ice cold DMEM containing 2.5% FCS to give a 10% W/V homogenate was added. 
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After douncing 20 times, the homogenate was centrifuged at 2,000 x g at 4˚C. The supernatant was 
collected and centrifuged at 10,000 x g at 4˚C. The clarified supernatant was aliquoted, stored 
at -80˚C and used to determine virus infectivity by plaque assay on BHK cells. The other half of 
each brain was stored in RNAlater stabilization solution (ThermoFisher Scientific) and used for 
RNA analysis. 
The brain halves stored in RNAlater solution were homogenized in dounce homogenizers that 
contained the correct amount of TRI Reagent (Molecular Research Center) needed to give a 10% 
W/V homogenate. Total RNA was extracted according to the manufacturer’s protocol. The 
concentration and quality of the RNA were determined using a Nanodrop UV-VIS 
spectrophotometer. The amount of viral RNA was quantified using a TaqMan one-step RT-PCR 
master mix reagent kit (Applied Biosystems) according to the manufacturer’s protocol. Reactions 
contained 300 µg of RNA. The primer and probe set targeted the WNV NY99 NS1 region 
(SigmaAldrich). The primer sequences were: forward primer 5′-GGCAGTTCTGGGTGAAGT-3′; 
reverse primer 5′-GCTTTCCGCTCTCTGTGGTGG-3′; Taqman probe 5′-6FAM-
TGTACGTGGCCTGAG-ACGCATACCTTGT-TAMRA-3′. WNV genomic RNA was 
normalized to cellular GAPDH in each sample and was quantified using a standard curve generated 
from serially diluted WNV NY99 genomic RNA of a known concentration.  
Real time quantitative reverse transcription-PCR (qRT-PCR) analysis of mouse ifnβ, oas1a and 
oas1b mRNA in mouse brains was performed in a 10 µl reaction containing 500 ng of total RNA 
as determined by NanoDrop, 1 µM of the target gene primer pair and 0.2 µM of the target gene 
probe. Applied Biosystems Assays-on-Demand 20x primer and fluorogenic TaqMan FAM/MGB 
probe mixes Mm00439552 for ifnβ, Mm00836412 for oas1a, and Mm0049297 for oas1b were 
used for each mRNA tested. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was 
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used as an endogenous control for each sample and was detected with TaqMAn mouse GAPDH 
primers and probe (Applied Biosystems). One-step RT-PCR was performed for each target gene 
and for the endogenous control using TaqMan RNA-to-Ct 1-Step Kit (Applied Biosystems). Each 
sample for each target was tested in triplicate. The cycling parameters were as follows: reverse 
transcription at 45°C for 15 min, TaqMan enzyme activation at 95°C for 10 min, denaturation at 
95°C for 15 secs, annealing/extension at 60°C for 1 min (cycle repeated 40 times). Values for 
target genes were normalized to GAPDH CT values and presented as fold change compared to 
mock.  
 
Immunofluorescence assay (IFA) of brain tissue. 
On different days following virus inoculation, mice were deeply anesthetized with isoflurane and 
then transcardially perfused first with ice cold PBS and then with 4% paraformaldehyde. The 
brains were then removed and cut into 1 mm sections using a tissue slicer (Stoelting, Wood Dale, 
IL) The sections were stored at 4˚C in 4% paraformaldehyde overnight and then transferred to 
30% sucrose until the sections sank. They were then moved to PBS. Prior to additional sectioning, 
the tissue was washed three times with PBS to remove any residual sucrose, embedded in O.C.T. 
compound and was then sectioned to create sections between 10 and 20 µm in width. The tissues 
sections were incubated at 4˚C with 5% normal horse serum (NHS) and 0.1% Triton-X overnight 
and then incubated with primary antibodies diluted in 5% NHS/0.1% Triton-X solution overnight 
at 4˚C. The antibodies used were mouse anti-dsRNA (English & Scienctific Consulting, Hungary, 
1:1000) and chicken anti-NeuN (Millipore, 1:250). Following primary antibody incubation, the 
sections were washed three times with PBS and incubated with donkey anti-mouse Alexa Fluor 
594 and donkey anti chicken Alexa Fluor 488 conjugated secondary antibodies diluted in 5% 
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NHS/0.1% Triton-X supplemented with Hoechst 33258 dye (DAPI) (Invitrogen) for one hour. The 
sections were then washed in PBS and mounted on microscope slides with Prolong Gold anti-fade 
reagent (Invitrogen). Images were obtained with a PerkinElmer UltraVIEW VoX spinning disc 
confocal fluorescence microscope and were processed using Volocity software (PerkinElmer).   
 
RESULTS  
Resistant mice lacking RNase L survive lethal doses of WNV and YFV.   
 RNase L was previously shown to have anti-WNV activity (Scherbik, Paranjape et al. 
2006). To determine whether the RNase L antiviral activity contributes to the Oas1b-mediated 
resistance phenotype in vivo, a strain of resistant mice lacking RNase L were generated. C57BL/6 
RNase L -/- mice (Zhou, Paranjape et al. 1997) were bred to flavivirus resistant C57BL/6 Oas1b+/+ 
mice (Scherbik, Kluetzman et al. 2007). The F1 progeny were then mated and the F2 mice were 
genotyped. Mice homozygous for both the resistance Oas1b allele and for the RNase L knockout 
allele were selected and used to establish a strain of C57BL/6 Oas1b+/+/RNase L-/- mice. 
 Groups of 6 to 8 week old mice of each of two C57BL/6 mouse strains homozygous for 
the susceptibility allele (Oas1btr), C57BL/6 WT and C57BL/6 RNase L-/-, and of each of two 
strains homozygous for the resistance allele (Oas1b), C57BL/6 Oas1b+/+ and C57BL/6 
Oas1b+/+/RNase L-/-, were inoculated by the IC route with either 500 PFU of YFV-17D or 100 
PFU of WNV NY99 and monitored for 25 days for signs of encephalitis. All of the C57BL/6 and 
C57BL/6 RNase L-/- mice inoculated with YFV-17D became moribund and were euthanized 
between 10 and 20 days after infection (Figure 2.1A). Mice of the same two strains inoculated  
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Figure 2.1 Survival curves for mice infected intracranially with a flavivirus. A) Survival 
curves for 6 to 8 week old C57BL/6 mice (n=14), C57BL/6 RNase L-/- mice (n=10), C57BL/6 
Oas1b+/+ mice (n=15) and C57BL/6 Oas1b+/+/RNase L-/- mice (n=15) infected with 500 PFU of 
YFV-17D vaccine. B) Survival curve of 6 to 8 week old C57BL/6 mice (n=11), C57BL/6 RNase 
L-/- mice (n=13), C57BL/6 Oas1b+/+ mice (n=11) and C57BL/6 Oas1b+/+/RNase L-/- mice (n=14) 
infected with 100 PFU of WNV NY99. Both viruses were diluted in sterile PBS and were 
intracranially injected with a volume of 10 µL. 
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with WNV NY99 became moribund and were euthanized between 5 and 11 days after infection 
(Figure 2.1B). In contrast, none of the C57BL/6 Oas1b+/+ or C57BL/6 Oas1b+/+/RNase L-/- mice 
infected with either virus displayed any detectable disease symptoms during the observation 
period. The data indicate that RNase L is not required for Oas1b-mediated resistance to flavivirus-
induced disease in mice.  
 
WNV production in the brains of resistant mice that express or lack RNase L.  
 Flavivirus yields are lower in the brains of flavivirus resistant mice than in susceptible mice 
(Brinton, Arnheiter et al. 1982, Urosevic, van Maanen et al. 1997). Although the lack of RNase L 
did not negatively affect the survival time of Oas1b+/+/RNase L-/- mice after a flavivirus infection, 
it was possible that the lack of RNase L increased virus yields in resistant mouse brains. To test 
this possibility, groups of 6 to 8 week old C57BL/6, C57BL/6 RNase L-/-, C57BL/6 Oas1b+/+, and 
C57BL/6 Oas1b+/+/RNase L-/- mice were infected intracranially with 100 PFU of WNV and virus 
titers in brains homogenates were determined on days 2 through 8 post infection (dpi) by plaque 
assay (Figure 2.2). At 2 dpi, the levels of infectious virus in the brains was low (2-2.5 log) for all 
four strains of mice. At 3 dpi, the virus titers in the brains of the C57BL/6 RNase L-/- mice had 
increased by ~100-fold compared to the brains of C57BL/6 while the titers for the other three 
strains was comparable to the levels at 2 dpi. At 4 dpi, the C57BL/6 and C57BL/6 RNase L-/- virus 
titers had increased by approximately 1200-fold and 2800-fold, respectively, while the titers in the 
brains of the two resistant strains had only increased by 3-fold.  Peak virus yields were observed 
for all four of the mouse strains at 5 dpi and were: 106.8 PFU/g in the C57BL/6 RNase L-/- brains, 
106 PFU/g in the C57BL/6 brains, 103.2 PFU/g in the C57BL/6 Oas1b+/+ brains and 103 PFU/g in 
the C57BL/6 Oas1b+/+/RNase L-/- brains. The virus titers in the brains of the two resistant strains  
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Figure 2.2. Infectious virus yields in brains of flavivirus resistant and flavivirus susceptible 
mice infected with WNV. Six to eight week old C57BL/6 mice (n=24), C57BL/6 RNase L-/- mice 
(n=21), C57BL/6 Oas1b+/+ mice (n=25) and C57BL/6 Oas1b+/+/RNase L-/- mice (n=28) were 
infected intracranially with 100 PFU of WNV NY99 diluted in sterile PBS in a volume of 10 µL. 
Infectious titers in brain tissue homogenates were determined by plaque assay on BHK cells. Each 
time point represents at least three animals. Data points represent mean value and error bars are 
S.E.M. *p<0.05; Mann-Whitney 
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decreased to undetectable levels by 8 dpi. These data show that C57BL/6 RNase L-/- mice produced 
increased virus yields compared to C57BL/6 but similar low titers were produced by resistant mice 
with and without RNase L.  
 
Comparison of the levels of WNV genome RNA in the brains of resistant mice that express 
or lack RNase L.  
 RNase L was previously shown to be able to cleave WNV genome RNA (Scherbik, 
Paranjape et al. 2006). To determine if RNase L played a role in decreasing viral genomic RNA 
levels, groups of 5 to 6 adult (6 to 8 weeks) C57BL/6, C57BL/6 RNase L-/- C57BL/6 Oas1b+/+, 
and C57BL/6 Oas1b+/+/RNase L-/- mice were infected with 100 PFU of WNV and their brains were 
harvested on various days post infection. Total RNA was extracted and the level of viral genomic 
RNA was determined by qRT-PCR (Figure 2.3). Similar low levels of virus RNA were detected 
in the brains of the C57BL/6, C57BL/6 Oas1b+/+, and C57BL/6 Oas1b+/+/RNase L-/- mice tested at 
2 dpi. However, the viral RNA levels were significantly higher at 1 dpi in the brains of the 
C57BL/6 RNase L-/- mice (Figure 2.3). By 4 dpi, viral RNA levels had increased dramatically in 
the susceptible C57BL/6 and C57BL/6 RNase L-/- brains but had increased only slightly in the 
resistant C57BL/6 Oas1b+/+ and C57BL/6 Oas1b+/+/RNase L-/- brains (Figure 2.3). The viral RNA 
levels further increased in the susceptible C57BL/6 mice on days 5 and 6. The viral RNA levels in 
the resistant C57BL/6 Oas1b+/+ and C57BL/6 Oas1b+/+/RNase L-/- increased only slightly on days 
4 and 5 and decreased on day 6. The data indicate that the presence of RNase L reduces the levels 
of viral RNA at early time (2 dpi) after infection. 
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Figure 2.3. RNA production in the brains of susceptible and resistant mice infected with
WNV. Six to eight week old C57BL/6 mice (n=24), C57BL/6 RNase L-/- mice (n=21), C57BL/6 
Oas1b+/+ mice (n=25) and C57BL/6 Oas1b+/+/RNase L-/- mice (n=28) were infected intracranially 
with 100 PFU of WNV NY99 diluted in sterile PBS in a volume of 10 µL. Brains were aseptically 
removed and total RNA was extracted using phenol-chloroform extraction. Viral RNA was 
quantified by qRT-PCR and the RNA copy number was determined by comparison to a standard 
curve generated with serially diluted NY99 genomic RNA of a known concentration. The level of 
viral RNA in each sample was normalized to GAPDH in that sample. Each data point represents 
RNA measurement from a single mouse brain. Horizontal bars represent the means. *p<0.05, 
****p<0.001; Unpaired student’s t-test. 
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Analysis of the Type 1 interferon response in the brains of resistant mice that express or lack 
RNase L 
 The induction of the Type 1 IFN pathway by WNV was analyzed in the brains of infected 
C57BL/6, C57BL/6 RNase L-/-, C57BL/6 Oas1b+/+, and C57BL/6 Oas1b+/+/RNase L-/- mice. Total 
RNA extracted from these brains and from mock infected animals was analyzed by qRT-PCR for 
ifnβ, oas1a and oas1b mRNA levels (Figure 2.4). At 2 dpi the ifnβ mRNA levels were 10-fold 
higher than the levels in mock infected brains for all four mouse strains. At 4 dpi and 6 dpi, the 
level of ifnβ mRNA was 1000-fold higher in C57BL/6 and C57BL/6 RNase L-/- mouse brains but 
only 10-fold higher in C57BL/6 Oas1b+/+ or in C57BL/6 Oas1b+/+/RNase L-/- compared to the level 
in mock brains (Figure 2.4A). The lower level of ifnβ mRNA expression in the brains of the 
resistant mice compared to the susceptible mice is consistent with the lower level of virus 
production in those brains.  
 Oas1a mRNA levels were 10-fold higher in C57BL/6 RNase L-/- and C57BL/6 
Oas1b+/+/RNase L-/- at 2 dpi compared to the levels in mock infected brains whereas the levels in 
C57BL/6 was 5-fold higher and in C57BL/6 Oas1b+/+ were 2-fold higher (Figure 2.4B). At both 4 
dpi and 6 dpi the levels of oas1a mRNA was 10-fold higher in C57BL/6 brains and ~100-fold 
higher in C57BL/6 RNase L-/- and C57BL/6 Oas1b+/+/RNase L-/- brains compared to mock infected 
brains (Figure 2.4B). The levels of oas1a mRNA in C57BL/6 Oas1b+/+ brains were ~2-fold higher 
at 4 dpi and ~10-fold higher at 6 dpi (Figure 2.4B).   
 The level of oas1b mRNA was <10-fold higher compared to mock infected brains at each 
day tested in C57BL/6 mice and was 10-fold higher in C57BL/6 RNase L-/- mice at 2dpi and then  
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Figure 2.4. Upregulation of IFN and Oas1 mRNA expression in the brains of susceptible and resistant 
mice infected with WNV. Six to eight week old C57BL/6 mice (n=6), C57BL/6 RNase L-/- mice (n=6), 
C57BL/6 Oas1b+/+ mice (n=6) and C57BL/6 Oas1b+/+/RNase L-/- mice (n=6) were infected intracranially 
with 100 PFU of WNV NY99 diluted in sterile PBS in a volume of 10 µL. Brains were aseptically removed 
and total RNA was extracted with phenol:chloroform. Brain RNA was analyzed for the levels of A) infβ, 
B) oas1a or C) oas1b mRNA using qRT-PCR. CT values were normalized to GAPDH in each sample fold 
change is relative to the levels in the brains of mock infected animals of each strain. Each data point 
represents a single mouse brain. Horizontal bars represent the means. 
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50-fold higher at 4 dpi and 6 dpi (Figure 2.4C). The average level of oas1b mRNA in the brains 
of the C57BL/6 Oas1b+/+ mice was ~50-fold higher at all times tested although at 6 dpi the level 
had dropped 10-fold in two of the mice tested (Figure 2.4C). The oas1b mRNA level in the 
C57BL/6 Oas1b+/+/RNase L-/- was 50-fold higher at 2 dpi but was more than 100-fold higher at 4 
dpi and 6 dpi (Figure 2.4C).  
 
 
Analysis of flavivirus RNA replication in mouse brain cells by IFA.  
 The intensity of the IFA signal for antibody to dsRNA indicates the level of viral RNA 
replication that is occurring in an infected cell. The kinetics of WNV RNA replication in cells in 
the brains of infected mice were investigated. Viral RNA replication complexes in infected cells 
in the brains of resistant C57BL/6 Oas1b+/+ mice and susceptible C57BL/6 mice were detected 
with anti-dsRNA antibody and neurons were detected with anti-NeuN antibody. On different days 
following intracranial inoculation with 500 PFU of YFV-17D or with 100 PFU of WNV NY99, 
mice were perfused with 4% paraformaldehyde and the brains processed for immunofluorescence 
using anti-dsRNA antibody and anti-NeuN antibody (Figure 2.5 & 2.6). At early times after 
infection (2 days for WNY NY99 and 4 days for YFV) the majority of NeuN-positive cells in 
fields of brain sections analyzed from both C57BL/6 and B57BL/5 Oas1b+/+ mice infected with 
either virus were positive for dsRNA (Figure 2.5 & 2.6). In neurons from both resistant and 
susceptible mice, the dsRNA signal was a thin perinuclear ring of similar signal intensity (Figure 
2.5 & 2.6). At later times after infection (4 dpi for WNB NY99 and 9 dpi for YFV), the intensity 
and area of the dsRNA signal had increased in the brains of the susceptible mice but neither the  
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Figure 2.5. Level of dsRNA staining in the brains of resistant and susceptible mice following 
infection with WNV NY99. Six to eight week old C57BL/6 mice or C57BL/6 Oas1b+/+ were 
infected intracranially with 100 PFU of WNV NY99 diluted in sterile PBS in a volume of 10 µL. 
At different days post infection, mice perfused with 4% PFA and the brains were sectioned and 
processed for IFA using anti-NeuN antibody (green) for neurons and anti-dsRNA antibody (red) 
for infected cells. Dapi (blue) was used to stain nuclei. Scale bars = 18 µm. Enlarged panel scale 
bars = 9 µm. 
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Figure 2.6. Level of dsRNA staining in the brains of resistant and susceptible mice following 
infection with YFV-17D. Six to eight week old C57BL/6 mice or C57BL/6 Oas1b+/+ were infected 
intracranially with 500 PFU of YFV-17D diluted in sterile PBS in a volume of 10 µL. At different 
days post infection, mice perfused with 4% PFA and the brains were sectioned and processed for 
IFA using anti-NeuN antibody (green) for neurons and anti-dsRNA antibody (red) for infected 
cells. Dapi (blue) was used to stain nuclei. Scale bars = 22 µm. Enlarged panel scale bars = 7 µm. 
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size nor intensity of the signal increased in the brains of the resistant mice (Figure 2.5 & 2.6). 
These data are consistent with the lower levels of viral genome RNA detected in resistant brains 
and indicate that the amplification of genome RNA replication in resistant mouse brains is 
inhibited at later times after infection. 
 
DISCUSSION 
 In response to invading RNA viruses, OAS proteins synthesize 2-5A to activate the 
endoribonuclease RNase L that non-specifically degrades RNAs in the cytoplasm. One murine 
OAS protein, Oas1b, is an inactive synthetase that confers resistance to flavivirus disease to mice 
through a mechanism that does not utilize 2-5A production (Elbahesh, Jha et al. 2011). However, 
mice encode other OAS proteins that are active synthetases and RNase L activation was previously 
shown to have anti-WNV activity (Scherbik, Paranjape et al. 2006, Elkhateeb, Tag-El-Din-Hassan 
et al. 2016). To determine the contribution of the anti-flavivirus activity of RNase L to flavivirus 
disease resistance, mice that were RNase L-/- were bred with resistant Oas1b+/+ mice and their 
response to infection with flavivirus was analyzed. Oas1b+/+/RNase L-/- mice had the same 
infection survival outcome and viral replication kinetics as resistant mice with RNase L. These 
results indicate that RNase L activation is not necessary for the full expression of the Oas1b-
mediated flavivirus disease resistance phenotype in mice. 
 The OAS/RNase L pathway was one of the first IFN-dependent antiviral pathways to be 
characterized, and has been shown to have antiviral activity against several RNA viruses including 
WNV (Scherbik, Paranjape et al. 2006). Replicative intermediate dsRNAs produced by viruses 
during replication are detected by the OAS proteins which synthesize 2-5A oligomers to activate 
RNase L. Secondary structures in viral genomes can also be detected by the OASs (Elbahesh, Jha 
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et al. 2011, Deo, Patel et al. 2015). Flaviviruses such as WNV sequester their dsRNA in replication 
vesicles composed of ER membrane invaginations that provide protection from detection and 
degradation by the OAS/RNase L pathway. These vesicles are detected by 8-10 hpi. Prior to the 
formation of these vesicles viral RNA is membrane associated but partially exposed and can 
activate the OAS pathway, leading to early RNA degradation (Welsch, Miller et al. 2009). In the 
current study C57BL/6 RNase L-/- mice had 10-fold higher levels of WNV genome RNA at 2 dpi 
(Figure 2.3), which likely contributed to the increased levels of virus production observed at 3 dpi 
compared to C57BL/6 mice (Figure 2.2). At 4 dpi and onward, the levels of WNV genome RNA 
were comparable between these two mouse strains, indicating that RNase L activity was no longer 
efficiently reducing genome RNA production. This timing coincided with the amplification of the 
dsRNA signal in neurons by 4 dpi, suggesting that the formation of replication vesicles had 
occurred and that exponential genome RNA production was taking place in the protective 
environment of these vesicles (Figure 2.5). There is no evidence that any WNV proteins can 
directly inhibit the activity of an OAS protein or of RNase L and sequestering of the replicating 
viral RNA is a critical component of WNV immune evasion strategy during infection in host cells. 
 Despite Oas1b being an ISG and despite the important role of Type 1 IFNs in controlling 
virus replication in cells, Type 1 IFN activity appears to be dispensable for the anti-flavivirus 
response in resistant mice (Brinton, Arnheiter et al. 1982). Comparison of the Type 1 IFN response 
in the brains of resistant and susceptible mice indicated that at 2 dpi, higher ifnβ mRNA levels 
were detected for all four animal strains tested compared to mock infected animals suggesting 
efficient activation of the IFN pathway (Figure 2.4A). At 4 and 6 dpi, there was no additional rise 
in ifnβ mRNA levels in resistant animals whereas the levels in susceptible rose by 100-fold. This 
increase in the ifnβ mRNA levels in susceptible mouse brains was accompanied by a rise in oas1a 
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mRNA levels but not in oas1b mRNA levels (Figure 2.4B, C). The higher level of oas1a mRNA 
detected in the brains of the two RNase L-/- strains is likely due to the lack of cell mRNA 
degradation by activated RNase L. The low levels of oas1b mRNA in susceptible C57BL/6 cells 
is likely due to a high turnover of the oas1b mRNA due to the presence of a premature stop codon.  
 Flavivirus genome RNA production in resistant mice and MEFs is exponentially lower 
compared to that in susceptible mice (Urosevic, van Maanen et al. 1997, Scherbik, Paranjape et al. 
2006). However, the levels of replicative intermediate RNAs were comparable between resistant 
and susceptible mice at early days following infection as detected by Northern blotting, providing 
additional evidence that the Oas1b-mediated inhibition of viral infection occurs at the level of plus 
strand RNA production (Urosevic, van Maanen et al. 1997). To directly observe the kinetics of 
viral RNA replication in neurons in vivo, infected resistant and susceptible mouse brains were 
stained with anti-dsRNA antibody. At later times in infection with either YFV or WNV the 
intensity of the dsRNA signal increased in susceptible mice but did not change in intensity in 
resistant mice. The size of the dsRNA signal area also increased in the susceptible mice suggesting 
an expansion of the replication vesicles, either in size or in number, inside the ER of the infected 
neurons. Neither the size nor the intensity of the dsRNA signal area increased with time in the 
infected neurons of the resistant mice. Inhibition of either the formation of new replication vesicles 
and/or of the mechanism mediating exponential genome replication inside the replication vesicles 
could be due to targeting of the full length Oas1b complex to the ER membrane via the Oas1b 
transmembrane domain. However, the mechanism by which Oas1b inhibits viral RNA synthesis 
is not yet known. 
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3 SPECIFIC AIM 2: CHARACTERIZATION OF THE RESPONSE OF HUMAN 
PLURIPOTENT STEM CELL-DERIVED CNS CELLS TO INFECTION WITH 
AVIRULENT AND VIRULENT STRAINS OF WNV 
INTRODUCTION 
 Viruses of the genus Flavivirus are arthropod-borne zoonotic pathogens that normally 
cause mild febrile illness but can also cause serious pathology including encephalitis, acute flaccid 
myelitis, hemorrhagic fever and microcephaly in children born to infected mothers. Mosquito-
borne flaviviruses that are known to cause severe disease in humans include West Nile virus 
(WNV), Dengue virus (DENV) and Zika virus (ZIKV) (Lindenbach, Murray et al. 2013). 
Flavivirus genomes are ~11,000 nt, single-stranded, positive sense RNA [(+)RNA] with a 5′-cap 
but no 3′-poly(A) tail . The genome serves as the viral mRNA with a single open reading frame 
(ORF) encoding three structural (capsid, envelope and prM) and seven non-structural proteins 
(NS1, NS2A, NS2B NS3, NS4A, NS4B, NS5). All of the non-structural proteins are involved in 
replicating the viral RNA and some are involved in evading the host cell immune response (Brinton 
2014).  
 Most WNV strains are classified into two distinct clades: lineage I and lineage II. Lineage 
I viruses are found throughout the world and are associated with outbreaks of CNS disease.  
Neurovirulent NY99 is a lineage I virus (Beasley, Li et al. 2002, Keller, Fredericksen et al. 2006). 
Lineage II viruses are endemic to Africa and have recently emerged in southern Europe (Zehender, 
Veo et al. 2017). Although both lineages include WNV strains that are neurovirulent and cause 
CNS disease and death following IC inoculation in mice, the lineage II strain MAD78 is not 
neurovirulent (Beasley, Li et al. 2002).  
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 In mice, pathogenic strains of WNV directly infects neurons in the basal ganglia, thalamus, 
midbrain, cerebellum and spinal cord (Shives, Tyler et al. 2017). Subsets of mouse primary 
neurons demonstrate varying sensitivity to infection by different strains of WNV due to differences 
in baseline expression of host defense genes and ISGs (Cho, Proll et al. 2013). WNV infection of 
mice astrocytes and microglial cells has also been observed (Quick, Leser et al. 2014). Histological 
analysis of CNS tissue from humans that succumbed to WNV encephalitis showed infected 
neurons in the brainstem, spinal cord, cerebellum, hippocampus and thalamus (Armah, Wang et 
al. 2007). Human primary neurons and astrocytes are permissive to infection by WNV although 
the efficiency of infection for some of these cell types varies with the WNV strain (Samuel, Whitby 
et al. 2006, Hussmann, Samuel et al. 2013, Quick, Leser et al. 2014).  
 Neural progenitor cells (NPCs) are found in the brain in the subventricular zone (SVZ) and 
the hippocampal dentate gyrus (DG) (Bond, Ming et al. 2015). During normal embryonic CNS 
development, NPCs differentiate into radial glial cells which then give rise either to astrocytes, 
microglial cells or neurons (Gotz and Huttner 2005). In adults, NPCs primarily respond to 
environmental cues with a diverse range of functions including neurogenesis, memory formation 
and response and repair to CNS injury (Garber, Vasek et al. 2018). Studies have shown that NPCs 
are permissive to infection by Zika virus (ZIKV) and Japanese encephalitis virus (JEV) and 
infection of NPCs by these viruses can inhibit cell proliferation and cause apoptosis (Tang, 
Hammack et al. 2016, Mukherjee, Singh et al. 2017). It is not currently known if any strains of 
WNV can infect NPCs in humans.  
 There are several factors that contribute to the development of CNS disease following 
infection with WNV. The Type I IFN response is a critical component of survival following WNV 
infection in mice. Type 1 IFN receptor-knockout mice infected with WNV have higher levels of 
37 
virus replication and succumb to infection faster than wild-type mice (Samuel and Diamond 2005). 
The ability of viruses to antagonize Type 1 IFN signaling is a determining factor for 
neurovirulence. Type 1 IFN knockout mice succumb to intracranial infection with nonpathogenic 
MAD78 whereas mice with intact Type 1 IFN signaling do not (Keller, Fredericksen et al. 2006). 
Inflammation in the CNS in response to WNV infection contributes to neuronal injury and disease 
progression. Mouse brains infected with WNV show increased expression of pro-inflammatory 
cytokines such as CXCL10, IL-6, CCL5 and TNF-α that facilitate trafficking of CD4+ and CD8+ 
T cells, natural killer cells and macrophages into the CNS (Samuel and Diamond 2009, Hussmann, 
Samuel et al. 2013, Clarke, Leser et al. 2014, Quick, Leser et al. 2014). These proteins are also 
secreted by human primary neurons and astrocytes in response to infection by WNV (Cheeran, Hu 
et al. 2005) Replication of WNV and other flaviviruses in CNS cells can lead to induction of 
caspase-3 and caspase-8-dependent apoptosis (Samuel, Morrey et al. 2007, Clarke, Leser et al. 
2014, Tang, Hammack et al. 2016). 
 The majority of studies on WNV-mediated CNS disease have been in mice or in post-
mortem tissue. The limited availability of human post-mortem tissue and of donor-to-donor cell 
variation present logistical problems for the use of this model. Mouse models are widely available 
and the use of inbred strains decreases genetic variation. However, findings in mice are not always 
directly applicable to humans. The use of human induced pluripotent stem cells (hiPSCs) to 
produce a wide variety of cells for study circumvents many of the issues of the traditional models. 
For this study, hiPSCs were differentiated into different types of neural cells that were used to 
study WNV infection. WNV neurovirulent NY99 and non-neurovirulent MAD78 were used to 
infect pure cultures of human NPCs, astrocytes, pre-mitotic neurons (PMN) or post-mitotic 
neurons (MN). The infections were characterized using traditional virology methods along with 
38 
Next Generation Sequencing (NGS) analysis of gene expression using global transcriptome 
analysis (RNA-seq).  
 
MATERIALS AND METHODS 
Cells and viruses 
Human iPSC lines were generated and maintained as previously described (Wen, Nguyen et al. 
2014). The differentiation of hiPSC into forebrain-specific NPCs was performed as previously 
described (Tang, Hammack et al. 2016). For all experiments with hiPSC-derived cells, the cells 
were seeded into wells coated with Matrigel (Corning). Briefly, 6-well plates, 12 well plates or 24-
well plates that contained coverslips were coated with ice cold Matrigel diluted 1:60 in DMEM/F-
12 (Gibco) for at least 2 hours at 37°C. Cultures of NPCs were dissociated with Accutase 
(ThermoFisher) at 37°C for 10 minutes. The cells were diluted with NPC media consisting of 
DMEM/F12 supplemented with B27 (ThermoFisher), N2 supplement, NEAA, 2 μg/ml of heparin 
(Sigma) and 2 μM cyclopamine (Tocris). ROCK inhibitor Y-27632 (5 µM) was added to the media 
prior to seeding the cells. For differentiation of NPCs into neurons, dissociated NPCs were diluted 
with Neurobasal medium (ThermoFisher) supplemented with B27, 2 mM Glutatmax (Gibco), 10 
ng/ml BDNF (PeprotTech), 10 ng/ml GDNF (PeproTech), 1 µM cAMP (SigmaAldrich), and 200 
ng/ml L-alanine and were seeded at a density of 5.6x104 cells/cm2. Astrocytes were maintained in 
Astrocyte Medium (ScienceCell Research Laboratories).  
Aliquots of WNV strain NY99 and WNV strain MAD78 were obtained from Dr. Robert Tesh 
(World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical 
Branch). Virus stocks were prepared by infecting confluent Vero monolayers at a MOI of 0.1. The 
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culture fluid was harvested at 36 hours post infection hpi, clarified by low speed centrifugation, 
aliquoted and stored at -80˚C. The titer of the WNV NY99 stock was 3.8x107 PFU/ml and the titer 
of the WNV MAD78 stock was 3.3x107 PFU/ml.  
 
Infection protocol 
Monolayers of NPCs, astrocytes, and neurons were infected at 37°C/5% CO2 for 1 hour with 
intermittent rocking. Briefly, culture media was aspirated and then virus diluted in cell media to 
the appropriate MOI was added to the cells. The media was brought to room temperature prior to 
adding virus to prevent the Matrigel coating from dissolving. After infection, the virus inoculum 
was removed and the cells were washed with HBSS and fresh media was replaced.  
The infectivity of WNV NY99 and WNV MAD78 samples was determined by plaque assay on 
BHK cells as previously described (Courtney, Di et al. 2012). Briefly, virus was serially diluted in 
MEM supplemented with 2.5% FBS and adsorbed on confluent BHK monolayers for 1 hour at 
37˚C. After the incubation period, the virus inoculum was aspirated and the monolayers were 
washed with HBSS and then overlaid with 2 ml/well of 1% SeaChem agarose (Bio-Whittaker 
Molecular Applications) mixed 1:1 with 2X MEM containing 5% fetal calf serum. The cells were 
incubated at 37˚C for 72 hpi and then stained using 0.05% crystal violet in 10% ethanol. All 
samples were assayed in duplicate.  
 
Drug treatment 
Cells were seeded on Matrigel coated 12 well plates. Monolayers were infected with WNV NY99 
(MOI=0.5). After the 1 hour adsorption period, the appropriate cell specific media with 1, 3, or 9 
µM PHA-690509 or 0.1, 0.3 or 0.9 µM Niclosamide diluted in 1 % DMSO was added to the wells.  
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Immunofluorescence Assay 
Matrigel coated coverslips in 24-well plates were seeded with NPCs or astrocytes. NPCs were 
maintained in NPC media or in neural induction media to produce neurons. Cells were infected 
with WNV NY99 or WNV MAD78 (MOI=2) or mock infected. At different times post infection, 
the media was aspirated and the cells were fixed with room temperature 4% paraformaldehyde for 
10 min. The cells were washed once with room temperature PBS and then incubated with 0.1% 
Triton-X for 10 minutes. The cells were then blocked in 5% NHS diluted in PBS for one hour at 
room temperature. Primary antibodies were diluted in 5% NHS and the cells were incubated 
overnight at 4 ̊ C. The cells were washed three times with PBS then were incubated with secondary 
antibodies diluted in 5% NHS containing 0.05% DAPI. The cells were washed three times with 
PBS, then were mounted on microscope slides with ProLong Gold (ThermoFisher). Cells were 
observed with a Zeiss Axio Observer Z1 inverted fluorescence microscope and images were 
analyzed with Volocity software (PerkinElmer). The antibodies used were mouse J2 anti-dsRNA 
(Scicons, 1:1000), goat anti-WNV NS3 (R & D Systems, 1:500), mouse anti-Nestin (Millipore, 
1:500), mouse anti-MAP2 (Millipore, 1:500), mouse anti-CTIP2 (Millipore, 1:500), rabbit anti-
GFAP (Dako, 1:500), rabbit anti-cleaved Caspase 3 (Cell Signaling, 1:500), and mouse anti-Ki67 
(Abcam, 1:500).  
 
Western Blotting 
Western blotting was done as previously described (Courtney, Di et al. 2012). Briefly, cell lysates 
were harvested in RIPA buffer containing protease inhibitor cocktail (Roche). Proteins were 
separated by SDS-PAGE and then transferred to nitrocellulose membrane. The membranes were 
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blocked with 5% milk in tris-buffered saline (TBS) with 0.1% Tween-20 (TBS-T) for 1 hour. 
Primary antibodies were diluted in blocking buffer and the membrane was incubated overnight at 
4 ˚C. The membranes were washed three times with TBS-T then incubated with secondary 
antibody in blocking buffer for one hour. Membranes were washed twice with TBS-T then once 
with TBS. Membranes were incubated in Super-Signal West Pico chemiluminescent substrate 
(ThermoFisher) and bands were detected using Las4000 mini Chemilumescent imager. The 
primary antibodies used were goat anti-WNV NS3 (R & D Systems, 1:1000) and mouse anti-β-
actin (Cell Signaling, 1:10,000).  
 
Cellular RNA extraction  
Triplicate monolayers of astrocytes in Matrigel-coated 6-well plates were infected with WNV 
NY99 at an MOI=0.5 or mock infected. Time points were taken at 24 and 48 hpi. Triplicate 
monolayers of NPCs or astrocytes in Matrigel-coated 6-well plates were infected with WNV 
MAD78 or WNV NY99 at an MOI=2 or mock infected. Time points were taken 12 and 24 hpi. 
Replicate cell cultures for both cell types were grown in 24 well plates Matrigel-coated coverslips 
and were also infected and used to determine the infection efficiency by IFA. For harvesting RNA, 
culture fluid was removed and cell lysates were harvested in 1 ml Tri-reagent (Molecular Research 
Center, inc). Total cellular RNA was extracted according to the manufacturer’s protocol. The RNA 
was quantified using Qubit RNA Broad Range Assay kit and stored at -80 ˚C (ThermoFisher).  
 
 
 
42 
RNA-seq and Transcriptome Analysis 
The library preparation and RNA-sequencing (RNA-seq) was performed by Novogene. Briefly, 
the mRNA poly(A) selected. RNA-seq libraries were generated from 1 μg of total RNA. RNA 
from triplicate samples of either mock infected or infected cells at different time points after 
infection were analyzed. The mRNA was fragmented randomly by adding fragmentation buffer, 
then cDNA was synthesized by using mRNA template and random hexamers primer. A custom 
second-strand synthesis buffer (Illumina), dNTPs, RNase H and DNA polymerase I were then 
added to initiate second-strand synthesis. After sequencing adaptor ligation, the double-stranded 
cDNA library was completed by size selection and Q-PCR enrichment using an Agilent 2100 
BioAnalyzer and a DNA1000 kit (Agilent). Illumina paired-end (PE) MiSeq (20 million 
reads/sample) sequencing was performed.  
Alignment, mapping, and differential expression (DE) analysis was performed in the Linux 
Operating System. Alignment of reads was carried out using Bowtie v.1.2.2 PE. RNA-seq reads 
were aligned to the human transcriptome annotation assembly (hg38) using Tophat v.2.1.1. 
Differential expressed gene (DEG) analysis was done using Cufflinks v.2.1.1. DEG data was 
analyzed using CummerBund v.2.7.2 in an R environment v.3.4. Gene ontology (GO) analysis for 
cellular pathways, biological processes, molecular function, and keywords were performed using 
Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.8 (Huang da, 
Sherman et al. 2009). Significantly enriched terms with a Benjamini-Hochberg score ≥0.05 were 
not used. Protein-protein interaction network analyses were performed by using GeneMania 
(Warde-Farley, Donaldson et al. 2010). 
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Cell counting  
Cultures of NPCs or SNB-19 cells were seeded in 6 well plates with or without Matrigel coating, 
respectively. Twenty-four hours after seeding, cell cycles were synchronized by treatment with 
2mM thymidine for 16 hours. After 16 hours, the cells were washed and fresh media was added. 
Cell counts were determined prior to adding virus. The cells were infected with WNV NY99 at a 
MOI=2. At 24 and 48 hpi, cell supernatants were harvested and centrifuged to pellet any cells that 
had detached during infection. Cell cultures were trypsinized and these cells were added to the 
tubes with the cell pellets. Cells were counted on a hemocytometer. Duplicate samples were 
counted at each time point. 
 
BrdU pulse-chase  
Cultures of SNB-19 cells were seeded into 6 well plates. When the cells were 50% confluent, they 
were infected with WNV NY99 at a MOI=2 or mock infected. After the incubation period, the 
virus inoculum was aspirated and media was added that contained 2 mM thymidine. Sixteen hours 
later, the thymidine media was removed and fresh media was added to the cells. For the BrdU 
pulse-chase, 100 mM BrdU was added to the wells without removing the media and the cell 
cultures were incubated for 30 minutes at 37˚C in the dark in a CO2 incubator. The cell media was 
then aspirated and the cells were washed twice with ice-cold PBS. The cells were then trypsinized 
and harvested. The cells were centrifuged at 500g for 5 minutes. The media was aspirated, and the 
cells were resuspended in 250 µl of ice-cold PBS. Ice cold 100% ethanol was added dropwise to a 
final volume of 1000 µl. The cells were stored at -20˚C until flow analysis.   
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Quantification of secreted pro-inflammatory cytokines 
Triplicate cultures of astrocytes were seeded in Matrigel coated 6 well plates and infected with 
WNV NY99 or WNV MAD78 (MOI=2) or mock infected. Astrocyte cultures grown on Matrigel 
coated coverslips in 24-well plates were also infected and analyzed by IFA to confirm infection 
and determine infection efficiency. Culture fluids from astrocytes infected with WNV MAD78 or 
WNV NY99 were collected at different times post infection. Pro-inflammatory cytokines CCL5, 
CXCL10 and IL-6 were quantified with enzyme-linked immunosorbent assay (ELISA) kits (R & 
D Systems) according to the manufacturer’s instructions. 
 
RESULTS 
WNV strain NY99 can efficiently infect four types of hiPSC-derived CNS cells 
  CNS cell types in mice previously shown to be permissive to WNV infection are neurons, 
microglial cells and astrocytes (Winkelmann, Luo et al. 2016). To determine which human iPSC-
derived CNS were permissive to WNV infection, pure cultures of NPCs, astrocytes, PMN and MN 
in Matri-gel coated plates from two different donor sources of hiPSCs were infected with WNV 
NY99 (MOI=0.5). The virus growth kinetics were determined by measuring the virus titer in the 
supernatant by plaque assay (Figure 3.1A). All four cell types from both donors replicated virus 
efficiently (Figure 3.1A). The MN cultures from both donors showed a higher amount of residual 
virus in the media following infection as indicated by the viral titers at 0 hpi, suggesting the 
possibility of less efficient viral entry compared to the other cell types.  To assess the infection  
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Figure 3.1. NY99 infection in four hiPSC-derived CNS cell types. Cultures of iPSC-derived 
NPCs, astrocytes, PMN or MN were infected with NY99 (MOI=0.5). A) Supernatants were 
harvested at the indicated times and the infectious viral titer was determined by plaque assay on 
BHK cells. B-D) Infected coverslips were fixed with 4% paraformaldehyde at 48 hpi and processed 
for IFA with anti-WNV NS3 antibody and B) anti-nestin, C) anti-MAP2 or D) anti-CTIP2. DAPI 
was using to stain nuclei. E) Quantification of number of infected cells in cultures of each cell 
type. Each data point represents the average from three replicate experiments. Error bars are 
standard error of the mean. 
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rate, infected cells on Matri-gel coated coverslips were fixed with 4% paraformaldehyde and 
processed by immunofluorescence assay (IFA) using an anti-WNV NS3 antibody and antibodies 
to Nestin for NPCs, GFAP for astrocytes, MAP2 for PMNs and CTIP2 for MNs (Figure 3.1B-D). 
In NPC cultures 50% of the cells were infected by 48 hpi and 80% by 60 hpi while for both types 
of neurons, 80% were infected by 48 hpi. The NPCs showed a decrease in the percent of infected 
cells by 72 hpi (Figure 3.1E). This was likely due to infected cells dying. In astrocyte cultures, 
20% of the cells were infected at 24 hpi and 60% were infected by 48 hpi (Figure 3.1E). The 
astrocyte cultures were rapidly killed by WNV NY99 infection as there were almost no attached 
cells remaining at 60 hpi (Fig 3.1E). These results indicate that WNV NY99 can efficiently infect 
and replicate in the four hiPSC-derived cell types.  
 
NY99 infection leads to caspase-3-dependent apoptosis in CNS cells  
 Neuronal cell death due to caspase-3-dependent apoptosis is a major contributor to CNS 
disease and death from WNV infection in mice (Samuel, Morrey et al. 2007). To determine the 
level of caspase-3-dependent apoptosis in hiPSC-derived cells infected with WNV, Matri-gel 
coated coverslips with NPCs, PMNs, or astrocytes were infected with NY99, fixed with 4% 
paraformaldehyde (PFA) at different times post infection, and then processed for IFA with an 
antibody for cleaved caspase 3 (Casp3+) (Figure 3.2A-D). Twenty percent of the NPCs were 
Casp3+ by 48 hpi and nearly 40% were positive by 72 hpi. Less than 5% of the mock infected cells 
were Casp3+ (Figure 3.2B). Four percent of the infected neurons were Casp3+ at 24 hpi and 12% 
were Casp3+ positive by 72 hpi (Figure 3.2D). The astrocytes showed no detectable caspase-3 
staining at any of the times tested after infection.   
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Figure 3.2. NY99 infection causes caspase-3-dependent cell death in NPCs and neurons. 
Cultures of A) NPCs or C) neurons seeded on coverslips were infected with NY99 (MOI=0.5) and 
were then processed for IFA with anti-cCasp3 antibody. B) Quantification of cCasp3 staining in 
infected and mock infected NPCs. D) Quantification of cCasp3 staining in infected and mock 
infected neurons. E) Neurons or H) NPCs were infected with NY99 and then treated with 20 µM 
emricasan in 1% DMSO or with 1% DMSO alone for up to 120 hours. E) Representative image 
of neurons treated with emricasan and then stained with anti-cCasp3 antibody. F) Quantification 
of cCasp3 staining in emricasan treated neurons and DMSO control cells. G) Viral titers from 
infected neurons with emricasan and without treatment. H) Representative IFA image of NPCs 
with and without emricasan treatment then stained with anti-cCasp3 antibody. F) Quantification 
of cCasp3 staining in emricasan treated NPCs and DMSO control cells G) Viral titers from infected 
NPCs with or without emricasan treatment. Each data point represents the mean from three 
biological replicate. Error bars are S.E.M.s ***p<0.005; student’s unpaired t-test. 
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 Emricasan is a pan-caspase inhibitor that is currently undergoing phase 2 clinical trials for 
treatment of liver disease (Sumida and Yoneda 2017). A recent screen of small-molecule inhibitors 
of  
Zika infection in NPCs and astrocytes showed emricasan could prevent caspase-3-dependent cell 
death following infection (Xu, Lee et al. 2016). The effectiveness of emricasan in protecting WNV 
infected CNS cells from caspase-3-dependent apoptosis was assessed. Following infection with 
NY99, NPCs and PMNs were incubated with emricasan or a 1% DMSO control for up to 120 hpi 
and analyzed by IFA using the Casp3+ antibody (Figure 3.2E, H). Casp3+ staining in both cell 
types treated with the drug was significantly lower at all times up to 72 hpi compared to the DMSO 
control (Figure 3.2F, I). The viral titer was determined at each time tested starting at 36 hpi (Figure 
3.2G, J). Emricasan treatment had little effect on the virus titer produced by NPCs compared to 
that produced by the DMSO control cells at any of the times tested (Figure 3.2J). Neuron cultures 
treated with emricasan produced similar virus titers to the DMSO control cultures through 72 hpi 
whereas the titers declined thereafter in the DMSO treated cells but remained high in the drug 
treated cultures (Figure 3.2G). The ability of caspase-inhibited neurons to maintain viral 
replication at high levels suggested a possible mode for the maintenance of a persistent infection.  
 
Analysis of the effects of antiviral compounds on WNV NY99 replication in NPCs and in 
astrocytes  
 A high-throughput screen of small molecule inhibitors against ZIKV infection in SNB-19 
cells yielded two candidate drugs that inhibited ZIKV infection in NPCs and in astrocytes (Xu, 
Lee et al. 2016). Niclosamide is an FDA-approved drug that has been used to treat tapeworm  
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Figure 3.3. Analysis of the effect of Niclosamide or PHA-690509 treatment of NY99 infected 
NPCs on WNV replication. Cultures of NPCs were infected with NY99 (MOI=0.5). After 
incubation with virus, the cells were washed and media was replaced that contained 1% DMSO 
with increasing concentrations of Niclosamide or PHA-690509 or 1% DMSO alone for 48 hours. 
A) Supernatants from infected cells were assessed for infectious virus by plaque assay on BHK 
cells. B) Cells seeded on coverslips were processed for IFA using an anti-dsRNA antibody and the 
number of infected cells quantified using Volocity software. C) Representative Western blot of 
cell lysates from either Niclosamide or PHA-690509 treated NPCs alongside DMSO control. D) 
Quantification of NS3 protein bands from Western blots by densiometric analysis using ImageJ 
software. NS3 band intensity was normalized to actin band intensity and measurements are relative 
to the DMSO control. Each data point represents the means from three biological replicates. Error 
bars are S.E.M. *p<0.05; **p<0.01;  ***p<0.005; ****p<0.001 by One-way ANOVA 
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infections in humans for 50 years (Kadri, Lambourne et al. 2018). PHA-690509 is an experimental 
cyclin-dependent kinase (CDK) inhibitor with no known therapeutic applications. These two 
compounds were tested for antiviral activity against WNV NY99 in NPCs and astrocytes. Cells 
seeded on Matrigel-coated coverslips in 24 well plates and also in Matri-gel coated 12 well plates 
without coverslips were infected with NY99 at an MOI=0.5. Media containing increasing 
concentrations of either Niclosamide or PHA-690509 in 1% DMSO were then added to the cells 
after the 1 hour absorption period. At 48 hpi, the supernatant was removed from the 24 well plates 
and the coverslips were fixed with 4% PFA and processed for IFA. Cell lysates from the 12 well 
plates were collected in RIPA buffer and analyzed by Western blotting.  
 Niclosamide treatment reduced the virus yield produced by NPCs (Figure 3.3) and 
astrocytes (Figure 3.4) in a dose dependent manner. Treatment of NPCs with Niclosamide 
decreased the viral titer by 1000-fold compared to the DMSO control at concentrations of 0.3 µM 
and 0.9 µM (Figure 3.3A). In contrast, treatment of astrocytes with 0.9 µM of Niclosamide 
decreased the virus yield by 10-fold (Figure 3.4A). The percent of cells infected was determined 
by IFA staining with anti-NS3 antibody in NPCs and with anti-dsRNA antibody in astrocytes. The 
percent of NPCs that showed a positive IFA signal for a viral marker after treatment with 0.3 µM 
Niclosamide was only 5% at 48 hpi and less than 1% after treatment with 0.9 µM Niclosamide. 
Eighty percent of the DMSO control cells were viral marker positive (Figure 3.3B). The percent 
of infected astrocytes decreased from 60% in the DMSO control cultures at 48 hpi to 30% after 
treatment with 0.9 µM of Niclosamide (Figure 3.4B). Viral protein translation was reduced by 
treatment of NPCs with all doses of Niclosamide tested as assessed by Western blotting for viral 
NS3 protein (Figure 3.3C, D). NS3 levels were also lower in astrocytes after treatment with 0.9  
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Figure 3.4. Analysis of the effect of Niclosamide or PHA-690509 treatment of NY99 infected 
astrocytes on WNV replication. Cultures of astrocytes were infected with NY99 (MOI=0.5). 
After incubation with virus, the cells were washed and media was replaced that contained 1% 
DMSO with increasing concentrations of Niclosamide or PHA-690509 or 1% DMSO alone for 48 
hours. A) Supernatants from infected cells were assessed for infectious virus by plaque assay on 
BHK cells. B) Cells seeded on coverslips were processed for IFA using an anti-dsRNA antibody 
and the number of infected cells quantified using Volocity software. C) Representative Western 
blot of cell lysates from either Niclosamide or PHA-690509 treated astrocytes alongside DMSO 
control. D) Quantification of NS3 protein bands from Western blots by densiometric analysis using 
ImageJ software. NS3 band intensity was normalized to actin band intensity and measurements 
are relative to the DMSO control. Each data point represents the means from three biological 
replicates. Error bars are S.E.M. ***p<0.005; ****p<0.001 by One-way ANOVA 
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µM Niclosamide for 48 hpi (Figure 3.4C, D). These data indicate that Niclosamide has antiviral 
activity against a WNV NY99 infection in both NPCs and astrocytes but is more effective in NPCs. 
PHA-690509 reduced the virus yield in NPCs by ~5-fold at 48 hpi but only at a concentration of 
9 µM (Figure 3.3A). In astrocytes, treatment with 9 µM of PHA-690509 decreased the virus yield 
by 10-fold at 48 hpi (Figure 3.4A). Treatment of NPCs with PHA-690509reduced the percent of 
detectable infected cells from ~80% in the DMSO control to 65% (3 µM) or to 20% (9 µM) at 48 
hpi (Figure 3.3B). In astrocyte cultures PHA-690509 treatment decreased the percent of infected 
cells from 60% in the DMSO control to 30% (3 µM) and 10% (9 µM) (Figure 3.4B). Viral protein 
translation inhibition was observed at 48 hpi after treatment of NPCs (Figure 3.3C) and of 
astrocytes (Figure 3.4C, D) with 3 or 9 µM of PHA-690509. These data indicate that PHA-690509 
also has antiviral activity against WNV NY99 in NPCs and astrocytes.  
 
Comparison of the efficiency of infections with WNV MAD78 and NY99 in NPCs and 
astrocytes  
 WNV MAD78 can infect primary human brain astrocytes and primary mouse neurons 
(Hussmann, Samuel et al. 2013) However, replication of other types of neural cells with this WNV 
strain have not been tested. The replication kinetics of WNV NY99 and WNV MAD78 were 
compared in human iPSC-derived cultures of NPCs and astrocytes. MAD78 efficiently infected 
NPCs (Figure 3.5A,B). In NPCs, the MAD78 virus yield showed a more rapid increase at 12 hpi 
compared to that of NY99 and reached peak titers at 24 hpi that were 5-fold higher than those of 
NY99 at 24 hpi. The yields of the two viruses were similar at 48 hpi and 72 hpi (Figure 3.5A). The 
percent of cells infected by MAD78 was higher than that for NY99 at 24 hpi (60% vs 25%) and at  
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Figure 3.5. MAD78 infection in hiPSC-derived NPCs and astrocytes. Cultures of iPSC-derived 
NPCs or astrocytes were infected with MAD78 (MOI=0.5) or NY99 (MOI=0.5). A, D) 
Supernatants were harvested at indicated times and infectious viral titer determined by plaque 
assay on BHK cells. B, E) Infected coverslips were fixed with 4% paraformaldehyde at the 
indicated time points and processed for IFA with antibodies against WNV NS3. C) Infected NPCs 
were processed for IFA with an anti-Casp3 antibody. The percentage of Casp3+ cells was 
quantified using Volocity software. Each data point is the average of three biological replicates. 
Error bars are S.E.M. 
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48 hpi (85% vs 50%) (Figure 3.5B). MAD78 activation of caspase-3 was assessed by IFA (Figure 
3.5C). The percent of Casp3+ cells in MAD78 infected NPCs cultures was very low and  
comparable to that in mock infected cultures at all times tested up to 72 hpi (Figure 3.5C). These 
data indicate that NPCs are permissive to infection by MAD78 and that MAD78 replicates more  
efficiently than NY99 in these cells. MAD78 did not activate caspase-3 cleavage in these cells by 
72 hpi (Figure 3.5C). 
 In astrocyte cultures, MAD78 had the same number of infected cells as NY99 (~25%) but 
fewer cells were infected in the MAD78 cultures compared to NY99 at 48 hpi (25% vs 60%). The 
observation that the percentage of infected astrocytes did not change between 24 and 48 hpi in 
MAD78 infected cultures indicated that few secondary infections had occurred. The percent of 
MAD78 infected astrocytes was ~50% at 72 hpi (Figure 3.5E). Virus titers produced by MAD78 
infected astrocytes rose faster than those produced by NY99 infected astrocytes before 24 hpi but 
were 0.5 log lower at 24 hpi and 1 log lower at 48 hpi and 72 hpi than NY99 (Figure 3.5C). These 
data are similar to those obtained by a study of MAD78 infection in primary human astrocytes 
(Hussmann, Samuel et al. 2013). The data indicate MAD78 is capable of infecting astrocytes, but 
does not spread efficiently in these cultures and does not produce as much infectious virus as 
cultures infected with NY99. 
 
Transcriptome analysis of NPCs infected with either WNV MAD78 or NY99 
 To investigate the differential effects of MAD78 and NY99 infections on gene expression 
in NPCS, RNA-seq was performed. Cultures of NPCs were infected with MAD78 or NY99 
(MOI=2). Efficient infection of the NPCs by each virus was confirmed by IFA with anti-dsRNA  
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Figure 3.6. Comparative transcriptome analysis at 12 hpi of NPCs infected with NY99 or 
MAD78. A) Total number of DEGs differentially regulated by both viruses with a 2-D Venn 
diagram showing common upregulated (green) and downregulated (gold) DEGs in NPCs at 12 hpi 
by NY99 (represented by warm colors) and MAD78 (represented by cool colors). Both viruses 
were used at MOI=2. B-E) GO enrichment analysis of DEGs using the terms biological process, 
molecular function, pathway and keywords. A Benjamini-Hochberg false discovery procedure was 
used and any term with p>0.05 was excluded. The histograms show enrichment terms of B) 
MAD78 12 hpi upregulated DEGs, C) NY99 12 hpi upregulated DEGs, D) MAD78 12 hpi 
downregulated DEGs and E) NY99 12 hpi downregulated DEGs.  
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antibody. Total cellular RNA was extracted at 12 and 24 hpi from infected and mock infected 
cultures on replicate cultures. The RNA was analyzed by MiSeq with PE reads by Novogene. At 
12 hpi, there were a total of 1048 DEGs in MAD78 infected NPCs and 1070 DEGs in NY99 
infected NPCs, with 594 of these genes upregulated by both viruses (Figure 3.6A). The 454 unique 
MAD78 DEGs constituted 43% of the total MAD78 DEGs, and the 475 unique NY99 DEGs 
constituted 44% of the total NY99 DEGs. At 24 hpi, there was a total of 7735 DEGs in MAD78 
infected NPCs and 7405 DEGs in NY99 infected NPCs with 5791 common DEGs (Figure 3.7F). 
There were 1921 unique DEGs in MAD78 infected NPCs (25% of total) and 1584 DEGs in NY99 
infected NPCs (21% of total) at 24 hpi (Figure 3.7F).  
 To determine what cellular processes were enriched by infections with these two viruses, 
up- and down-regulated DEGs with a ≥ 1.5-fold change in expression at 12 hpi and ≥ 2 fold change 
in expression at 24 hpi were analyzed for GO analysis using DAVID (Figures 3.6 & 3.7). GO 
enrichment analysis was limited to cellular pathways, biological processes, molecular function, 
and keywords. Three types of analyses were performed (1 the common DEGs that were altered by 
both viruses in infected cells, (2 the virus strain-specific DEGs, (3 and all of the DEGs for each 
virus that were upregulated above the established thresholds.   
 The MAD78 up-regulated DEGs in infected NPCs at 12 hpi were enriched for “protein 
processing in the ER”, “endoplasmic reticulum”, and “ER unfolded protein response”, with a total 
of 51 genes comprising these three categories (Figure 3.6B). “Antiviral defense”, “type I interferon 
signaling pathway”, and “defense response to virus” were also enriched with a total of 20 genes 
(Figure 3.6B). NY99 DEGs in infected NPCs at 12 hpi were enriched for “antiviral defense”, “type 
I interferon signaling pathway”, “defense response to virus”, and “response to virus” with 26 genes 
in these categories (Figure 3.6C). NY99 DEGs were also enriched for endoplasmic reticulum stress  
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Figure 3.7. Comparative transcriptome analysis at 24 hpi of NPCs infected with NY99 or 
MAD78. A) Total number of DEGs differentially regulated by both viruses with a 2-D Venn 
diagram showing common upregulated (yellow) and downregulated (orange) DEGs in NPCs at 24 
hpi by NY99 (represented by warm colors) and MAD78 (represented by cool colors). Both viruses 
were used at MOI=2. B-G) GO enrichment analysis of DEGs using the terms biological process, 
molecular function, pathway and keywords. A Benjamini-Hochberg false discovery procedure was 
used and any term with p>0.05 was excluded. The histograms show enrichment terms of B) 
MAD78 12 hpi upregulated DEGs, C) NY99 12 hpi upregulated DEGs, D) MAD78 12 hpi 
downregulated DEGs and E) NY99 12 hpi downregulated DEGs. F) Unique DEGs that were only 
upregulated in MAD78 infected NPCs. G) Unique DEGs that were only downregulated in NY99 
infected NPCs. 
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genes with 18 genes in the categories “IRE-1-mediated unfolded protein response”, “protein 
processing in ER”, and “ER chaperone complex” (Figure 3.6C).   
 Up and downregulated DEGs common to infections with both viruses at 12 hpi were 
analyzed for enrichment. “Focal adhesion”, “endoplasmic reticulum”, “extracellular matrix 
organization” and “protein processing in endoplasmic reticulum” were up regulated with 49, 65, 
27 and 26 genes in each category, respectively (Figure 3.6D). Both viruses infections had down 
regulated DEGs enriched for “developmental protein”, “neuron differentiation”, “neuron 
development”, and “neurogenesis” with 44 common DEGs shared by both viruses that fit into 
these four categories (Figure 3.6E).  
 MAD78 upregulated DEGs in infected NPCs at 24 hpi were enriched for “protein 
processing in endoplasmic reticulum”, “antiviral defense”, “stress response”, and “IRE1-mediated 
unfolded protein response” with 37, 29, 24 and 19 proteins in each category, respectively (Figure 
3.7B). MAD78 and NY99 down regulated DEGs were enriched for “glycoprotein”, “signal”, 
“calcium”, and “extracellular matrix” with 844, 741, 158, and 221 genes in each category 
respectively with a total of 1002 individual genes (Figure 3.7E). “Nervous system development” 
and “neurogenesis” were also downregulated by both viruses with 149 genes in these two 
categories (Figure 3.7E). NY99 infection upregulated DEGs were enriched for ER stress responses 
with 74 individual genes in four categories related to protein processing in the ER (Figure 3.7C). 
NY99 infected NPCs were also enriched for “antiviral defense” with 21 genes in this category 
(Figure 3.7C).  
 Common DEGs that were upregulated by the two viruses at 24 hpi were enriched for 
“protein binding”, “protein transport”, and “protein processing in the ER”, with 2538 individual 
genes in these three categories (Figure 3.7D). “Alternative splicing” was also enriched with 1874 
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DEGs and “apoptosis” with 148 DEGs (Figure 3.7D). GO analysis of DEGs at 24 hpi that were 
unique to MAD78 or to NY99 infection revealed several terms that were oppositely regulated by 
the two virus infections (Figure 3.7F, G). The term “nucleus” was enriched in upregulated MAD78 
DEGs with 519 unique DEGs but 313 unique NY99 DEGs were downregulated in this category. 
While the term “alternative splicing” contained 1874 common upregulated DEGs, there were also 
837 unique upregulated DEGs for MAD78 and 548 unique downregulated DEGs for NY99 (Figure 
3.7F, G). Additionally, the terms “cell cycle” and “cell division” had 101 and 72, respectively, 
unique upregulated DEGs for MAD78 and had 61 and 35, respectively, unique downregulated 
DEGs for NY99 (Figure 3.7F, G).  
 
WNV infection of CNS cells modulates the cell cycle and decreases cell proliferation 
 An RNA-seq analysis of NPCs infected with ZIKV and DENV indicated the expression of 
genes associated with the cell cycle and cell proliferation was downregulated by both viruses 
(Zhang, Hammack et al. 2016). Our analysis showed that infection of NPCs by WNV NY99 also 
modulated the expression of genes associated with the cell cycle (Figure 3.7 F, G, Table 3.1 & 
3.2). Upregulated DEGs were associated with negative regulation of the G1/S phase transition 
(Table 3.1). Downregulated DEGs were associated with initiation of DNA synthesis (Table 3.2). 
Of particular note were the downregulated minichromosome maintenance complex (MCM) 
proteins which are necessary for initiating DNS synthesis at the G1/S phase transition (Deegan 
and Diffley 2016). To further investigate, 165 up- and downregulated DEGs at 24 hpi that enriched 
for the terms “cell cycle” and “cell division” were analyzed by protein-protein and genetic 
interaction network analysis using GeneMania. GeneMania searches biological datasets for 
information on genes that are confirmed to physically interact, either directly or in complexes, or  
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Table 3.1. List of DEGs that were upregulated by NY99 infection in NPCs 
 
 
 
 
 
 
Table 3.2. List of DEGs that were downregulated by NY99 infection in NPCs 
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are part of genetic interaction networks (Warde-Farley, Donaldson et al. 2010) (Figure 3.8). The 
protein-protein interaction network analysis revealed that many of the genes more centrally located 
in the network, meaning these genes products have multiple interaction partners within the 
network, were downregulated DEGs in NY99 infected NPCs. All but two of these twelve 
downregulated DEGs were associated with “DNA replication” (Figure 3.8). Many of the 
upregulated DEGs were found at the periphery of the network, meaning that they only have a few 
interacting partners (Figure 3.8). This finding suggests that these gene products are targeting key 
regulators in the network. For example, the transcription factor AHR has a genetic link with cyclin-
dependent kinase inhibitor 1a (CDKN1A), which in turn has multiple interaction partners 
including CDK2 (Marlowe and Puga 2005) (Figure 3.8). These data indicate that modulation of 
the expression of particular sets of genes by NY99 infection of NPCs may inhibit DNA replication 
and cell cycle progression.  
 To analyze the effect of WNV-mediated cell cycle perturbation on infected neural cells, 
glioblastoma cells (SNB-19) and NPCs were infected with NY99 (MOI=2) or mock infected and 
the cells were trypsinized, harvested and counted with a hemocytometer either just before infection 
and at 24 and 48 hpi (Figure 3.11A, B). To account for cells that detached due to the effects of the 
infection, supernatants were also harvested and centrifuged to obtain the cells that were floating in 
the media and these were added to the trypsinized cell samples. At 24 and 48 hpi, the number of 
SNB-19 cells was significantly greater (p<0.001) in the mock infected wells compared to the NY99 
infected wells (Figure 3.11A). The ratio of mock infected SNB-19 cells to virus infected cells was 
1.5x at 24 hpi and ~2x at 48 hpi (Figure 3.11C). At 24 hpi the number of mock infected and NY99 
infected NPCs was similar but at 48 hpi the number of mock infected NPCs was significantly 
higher (p<0.01) than the number of NY99 infected cells (Figure 3.11B). The ratio of mock infected  
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Figure 3.8. Protein-protein interaction network analysis of cell cycle-related DEGs during 
infection of NPCs by NY99. A protein-protein interaction and genetic interaction network map 
highlighting genes that are involved in “G1/S transition of mitotic cell cycle”, “DNA replication”, 
“cell cycle arrest” and “regulation of cell cycle arrest” and are DEGs in NY99 infected NPCs. 
Genes closer to the center have more interactions with other members of the network while genes 
toward the periphery have fewer numbers of interacting partners. Genes connected by red lines 
have direct protein-protein interactions whereas genes with green lines are genetically connected. 
The red circles indicate downregulated DEGs and the green circles indicate upregulated DEGs. 
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Figure 3.9. Inhibition of CNS cell proliferation by a NY99 infection. NY99 infected (MOI=2) 
A) SNB-19 cells and B) NPCs were counted at the indicated hpi. Zero points were cells counted 
before infections. C) Ratio of number of cells in mock cultures to those in infected cultures. D) 
SNB-19 cells were infected with NY99 (MOI=2), fixed by 4% PFA at the indicated hpi, and 
stained with anti-Ki67, anti-GFAP, and anti-NS3 antibodies. Images shown are representative of 
three biological repeats. E) Ki67+ nuclei were quantified using Volocity software. Data points are 
means from three biological replicates. Error bars are S.E.M. ****p<0.001; One-way ANOVA. 
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NPCs to NY99 infected NPCs was 1.6x at 48 hpi (Figure 3.11C). These data indicate that NY99 
infection of both SNB-19 cells and NPCs inhibited cell division.  
 To determine if cell proliferation was inhibited in the infected cultures, SNB-19 cells 
infected with NY99 were fixed with 4% PFA and processed for IFA using anti-WNV NS3 
antibody, anti-GFAP antibody as a cell marker, and an antibody to the cell proliferation marker 
Ki67, which binds to mitotic chromosomes after nuclear envelope disassembly (Cuylen, Blaukopf 
et al. 2016) (Figure 3.11D). At 24 hpi, the percent of cells with Ki67+ nuclei was similar between 
NY99 infected and mock infected SNB-19s cultures. At 48 hpi, there were significantly more 
(p<0.001) cells with Ki67+ nuclei in the mock infected SNB-19 cultures than in the NY99 infected 
cultures (Figure 3.11D). These data indicate that infection with WNV NY99 does inhibit cell 
proliferation in SNB-19 cells. 
 Cell cycle arrest can be initiated by the cell at multiple steps in the cell cycle in response 
to a wide variety of stimuli. Ki67-binding, as detected in proliferation assays, occurs at the G2 
phase in mitotic cells, which is the last phase before mitosis (Whitfield, George et al. 2006). The 
analysis of DEGs downregulated by WNV at 24 hpi indicated downregulation of the MCM family 
of genes, which are involved in DNA replication, and indicates that cell cycle arrest likely occurs 
prior to the G2 phase (Figure 3.9). To determine when in the cell cycle the WNV-mediated cell 
cycle perturbation occurs, DNA synthesis was assessed by a BrdU-pulse assay. The efficiency of 
BrdU incorporation and the total DNA content by propidium iodide (PI) staining was assessed by 
flow cytometry (Figure 3.11B, C). For both mock and infected cells at the time of release, the 
percent of cells in S-phase was extremely low 0.82% and 0.66% respectively. The percent of 
untreated, mock infected cells was 21.3% (Figure 3.12B, C). At 2 and 4 hours post release (hpr), 
the percent of cells in early and late S-phase in mock infected cells and WNV-infected cultures  
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Figure 3.10. Analysis by BrdU pulse-labeling of DNA synthesis in SNB-19 cells infected with 
NY99. A) Timeline of protocol for BrdU pulse-labeling experiment. SNB-19 cells were infected 
with NY99 (MOI=2). After infection, thymidine was added to the cells for 18 hours. The thymidine 
was then removed and the DNA were incubated with BrdU at the indicated times post release. 
Cells were harvested, labeled for DNA content by propidium iodide staining, and analyzed by flow 
cytometry. B) BrdU-labeling of cells prior to thymidine release. C) BrdU-pulse labeling of cells 
after thymidine release. Images shown are representative of two biological replicates. 
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was approximately equal (Figure 3.12C). At 6 hours, 29.6% of the mock infected cells were in 
early S-phase and 48.9% of the cells were in late S-phase, while 40.4% of the infected cells were 
in early  
 S-phase and 34.8% were in late S-phase. At 8 hpr, 6.65% of the mock infected cells were 
in early S-phase and 30.5% of the cells were in the G2 phase while 14.8% of the infected cells 
were in early S-phase and only 15.9% were in the G2 phase. Additionally, 26.2% of the cells in 
infected cultures were in the G1 phase but only 18.9% of the cells in the mock cultures were in the 
G1 phase. At 10 hpr, 30.7% of the mock infected cells were in the G2 phase and 19.9% were in 
the G1 phase. In the 10 hpr infected cultures 16.6% of the cells were in the G2 phase and 25.1% 
were in the G1 phase (Figure 3.12C). These data indicated that WNV-infected SNB-19 cells 
experienced G1/S phase arrest following release from thymidine-mediated cell cycle arrest. 
 To determine if cell cycle arrest had a beneficiary effect on virus replication, S-phase arrest 
was induced through treatment of cells with either 2 mM of thymidine or 12 µM of aphidicolin 
(APH). APH binds to the active site of B-family DNA polymerases, preventing DNA synthesis 
and arresting cells at the G1/S interface (Baranovskiy, Babayeva et al. 2014). SNB-19 cells were 
incubated with 2 mM thymidine to synchronize their cell cycles, released for 12 hours, and then 
infected with NY99 in media containing 1% DMSO and either 2 mM thymidine or 12 µM APH 
or 1 % DMSO alone. Infected cells were analyzed by Western blotting with an anti-NS3 antibody 
(Figure 3.13A) and by qRT-PCR (Figure 3.13C). Treatment of cells with thymidine increased viral 
NS3 levels significantly (p<0.05) over the DMSO control cells but APH treatment had little effect 
(Figure 3.13A, B). Intracellular viral genomic RNA levels were elevated in thymidine and APH 
treated cultures compared to the DMSO control cultures at 24 hpi but not 48 hpi (Figure 3.13C). 
These data indicate that S-phase arrest has a beneficiary effect on WNV infection in SNB-19 cells. 
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Figure 3.11. Effect of cell cycle arrest on WNV infection of SNB-19 cells. Cultures of SNB-19 
cells were treated with 2 mM thymidine for 12 hours and then were released for 12 hours. The 
cells were then incubated with either 2 mM thymidine, 12 µM APH, or DMSO control for 16 
hours. The cells were then infected with NY99 (MOI=1). A) Representative western blot image of 
WNV infected cell lysates harvested at 24 hpi. Membranes were probed with anti-NS3 antibody. 
B) Quantification of relative NS3 intensity from three biological repeats. *p<0.05; two-tailed t-
test. C) Total intracellular RNA from SNB-19 cells was extracted at 24 hpi and 48 hpi and analyzed 
by RT-qPCR. Representative data from one biological replicate is shown. Three biological 
replicates were performed. 
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Astrocytes infected with WNV NY99 express pro-inflammatory cytokine genes   
 Astrocytes infected with WNV NY99 produce several inflammatory cytokines that can 
contribute to cell death and may also contribute to neuroinvasion and CNS disease in mice (Wang, 
Town et al. 2004, van Marle, Antony et al. 2007, Choi, Lee et al. 2014). To determine if NY99 
infection of the hiPSC-derived astrocytes increased expression of pro-inflammatory cytokine 
genes, astrocytes infected with NY99 (MOI=1) were analyzed by RNA-seq. WNV-infected and 
mock infected astrocyte monolayers were lysed with TRI Reagent at 24 and 48 hpi and the 
intracellular RNA was isolated by phenol chloroform extraction. Mock infected cultures were used 
to determine the fold change of DEGs. The RNA was analyzed by MiSeq with paired-end reads 
by Novogene. Infection efficiency was assessed on replicate infected cultures grown on coverslips 
by IFA using an anti-dsRNA antibody. The infection rate was 35% at 24 hpi and 72% at 48 hpi 
(Data not shown). 
 There were 9448 and 9863 up-regulated NY99 DEGs at 24 and 48 hpi, respectively, with 
6945 common upregulated DEGs between the two times (Figure 3.8A). There were 9007 and 
12093 downregulated NY99 DEGs at 24 and 48 hpi, respectively, with 6708 downregulated DEGs 
common to both times (Figure 3.8B). GO enrichment analysis using DAVID was performed for 
the terms biological process, molecular function, keywords, and cellular pathway. Genes 
associated with immune response against viruses were upregulated at both times compared to 
mock infected cells (Figure 3.8C, D). At 48 hpi, upregulated DEGs were enriched for “cytokine” 
and “apoptosis” (Figure 3.8D). At 24 hpi and 48 hpi, the expression levels of IFNL1, CCL3, CCL5, 
interleukin-6 (IL-6), CD40 and CD70 were highly upregulated (Figure 3.9A). Increased expression 
levels of IFNβ, CXCL10, OAS2, and OAS3 were also observed (Figure 3.9A). 
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Figure 3.12. Transcriptome analysis of hiPSC-derived astrocytes infected with NY99. A & 
B) 2-D Venn diagram of A) upregulated DEGs and B) downregulated DEGs in NY99 infected 
iPSC-derived astrocytes (MOI=2). GO analysis for enrichment of biological process, molecular 
function, pathway and keywords that were C & D) upregulated by NY99 infection at C) 24 hpi 
and D) 48 hpi and E & F) downregulated at E) 24 hpi and F) 48 hpi. 
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 To test if inflammatory cytokines were being secreted by hiPSC-derived astrocytes infected 
with WNV NY99, and to see if a WNV MAD78 infection also induced pro inflammatory cytokines 
to the same level, supernatants harvested at 48 hpi and 60 hpi from NY99 and MAD78 infected 
cultures (MOI=2) of hiPSC-derived astrocytes were assayed by ELISA for IL-6, CXCL10, and 
CCL5 (Figure 3.9B-D). At 48 hpi, the secretion of all three proteins was elevated but the levels 
were not significantly different between the supernatants from the two different virus infections 
(Figure 3.9B-D). At 60 hpi, the NY99-infected astrocytes produced significantly higher levels of 
CCL5 (Figure 3.9B) and CXCL10 (Figure 3.8C) compared to the MAD78 infected astrocytes. The 
observed level of IL-6 in the from MAD78 and NY99 infected astrocytes may be inaccurate as it 
was over the detection limit of the assay. These results show that infection of astrocytes by both 
viruses induces secretion of pro-inflammatory cytokines CXCL10, IL-6 and CCL5.  
 
DISCUSSION 
 WNV is currently the leading cause of virus-induced encephalitis in the United States 
(Burakoff, Lehman et al. 2018). Studies in mice have indicated that WNV can infect several 
neuronal subtypes, astrocytes and microglia (Diniz, Da Rosa et al. 2006, Cho, Proll et al. 2013, 
Quick, Leser et al. 2014). Similar to the findings in mice, primary human astrocytes and neurons 
are permissive to infection by pathogenic WNV NY99 (Cheeran, Hu et al. 2005). In the current 
study, the pathogenic WNV lineage I strain NY99 was shown to efficiently infect and replicate in 
cultures of human iPSC-derived NPCs, astrocytes, pre-mitotic neurons and post-mitotic neurons 
(Figure 3.1). These data support previous findings in the literature using a new model for studying  
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Figure 3.13. WNV infected astrocytes produce pro-inflammatory cytokines. A) Increased 
expression of several pro-inflammatory genes revealed by RNA-seq analysis of NY99 infected 
astrocytes at 24 and 48 hpi. ELISA was performed on supernatants from MAD78 and NY99 
infected astrocytes to detect secreted B) CCL5, C) CXCL10, and D) IL-6. Each histogram is the 
mean from three replicate experiments and error bars represent S.E.M. *p<0.05, **p<0.01, 
student’s t-test, two tailed. 
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human WNV CNS disease and implicate NPCs as targets of WNV infection for the first time. 
NPCs are CNS stem cells that are important components of not only normal fetal CNS 
development but also adult CNS maintenance, especially following injury (Bond, Ming et al. 
2015). Patients with confirmed WNV-mediated CNS disease had significant neuropsychological 
impairment one year after symptoms had resolved, suggesting long term damage to the CNS 
(Sadek, Pergam et al. 2010). The ability of WNV to directly infect human NPCs and cause 
apoptosis via caspase-3 cleavage (Figure 3.2B) could reduce the pool of NPCs available for the 
CNS repair that occurs following clearance of WNV from the brain, which would contribute to 
prolonging CNS impairment. 
 The non-pathogenic WNV MAD78 also infected astrocytes (Figure 3.5D) and caused 
secretion of pro-inflammatory cytokines (Figure 3.9) but did not spread as efficiently in these cells 
as the pathogenic WNV NY99 (Figure 3.5E). The percent of astrocytes infected by the two viruses 
was comparable at 24 hpi. At 48 hpi the percent of NY99 infected cells had increased but in the 
MAD78 infected cultures, the percent of infected cells had not increased (Figure 3.5E). A more 
limited ability of MAD78 to infect astrocytes could prevent this virus from efficiently crossing the 
blood brain barrier and causing neuroinvasive disease (Winkelmann, Luo et al. 2016). 
Interestingly, at 24 hpi, the viral yield produced by MAD78 infected astrocytes was only 0.5 log 
lower than that produced by NY99 and only 1 log lower by 48 hpi, suggesting that MAD78 virus 
production was efficient in the astrocytes that were infected compared to NY99. It was the 
secondary rounds of infection by progeny MAD78 virus that was impeded. A suggested 
explanation in a previous study is that the progeny MAD78 virus produced from astrocytes cannot 
efficiently infect astrocytes due to astrocyte-specific modifications to the viral structural proteins 
that inhibit maturation of the virus particles in the golgi apparatus prior to viral egress (Hussmann, 
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Vandergaast et al. 2014). This lack of ability to induce secondary rounds of infection may 
contribute to the observed decreased cytokine production by astrocytes infected with MAD78 
compared to NY99 (Figure 3.9). 
 This study reports the first comparative transcriptome analysis of hiPSC-derived NPCs 
infected with NY99 and MAD78. Infection by either of these viruses activated ER stress pathways 
and the unfolded protein response (UPR) by 12 hpi (Figure 3.6B, C). Activation and modulation 
of the UPR and the ER stress response by DENV, ZIKV, JEV and WNV infections has previously 
been reported (Blazquez, Escribano-Romero et al. 2014, Hou, Kumar et al. 2017). The role that 
the UPR plays in viral replication is not well understood. ER stress leads to increased ER 
membrane proliferation that can facilitate cell survival and also serve as a platform for virus 
replication (Lee, Kuo et al. 2018). Activation of the IRE1-mediated unfolded protein response 
results in excision of an intron from the transcription factor xbox-binding protein 1 (XBP1) mRNA 
that stabilizes the transcription factor protein produced and this transcription factor upregulates 
multiple UPR genes (Iranpour, Moghadam et al. 2016). Although XBP1 expression was 
upregulated by infection with both WNV viruses at 24 hpi in NPCs, XBP1 expression was 
previously shown not to be required for DENV or WNV replication (Iranpour, Moghadam et al. 
2016, Lee, Kuo et al. 2018). The efficiency of cleavage of the xbp1 mRNA was not analyzed. 
 The translation of large amounts of viral protein and the insertion of these proteins into the 
ER membrane could increase the accumulation of unfolded proteins in the cell. For both viruses, 
DEG enrichment for genes involved in protein binding and protein transport was observed (Figure 
3.7D). Protein binding DEGs were mainly comprised of chaperone proteins, such as the DNAJ 
family of proteins. The DNAJ/Hsp40 family is a large group of proteins that facilitate cell survival 
by assisting with proper protein folding using ATP-hydrolysis (Mogk, Bukau et al. 2018, 
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Zarouchlioti, Parfitt et al. 2018). Flaviviruses may requisition host chaperone proteins to facilitate 
replication. Two DNAJ family members, DNAJC14 and DNAJA1, have been previously 
implicated as being important for flavivirus replication by YFV and JEV (Wang, Huang et al. 
2011, Taguwa, Maringer et al. 2015). The contribution of other members of this family of proteins 
to WNV infection is not known. 
 A recent analysis of infection outcomes in a mouse model of long term effects after 
surviving WNV CNS disease indicated that NPCs differentiated into proinflammatory astrocytes 
in response to WNV infection in the CNS and that this depletion of the NPC pool prevented 
efficient CNS repair leading to prolonged CNS damage and behavioral dysfunction (Garber, Vasek 
et al. 2018). The authors suggest that this switch was facilitated by the secretion of pro-
inflammatory cytokines during infection (Garber, Vasek et al. 2018). Our RNAseq analysis 
indicated that MAD78 and NY99 infected NPCs caused downregulation of DEGs associated with 
“neurogenesis” and “nervous system development” (Figure 3.7E). Additionally, NY99 infection 
induced increased expression of pro-inflammatory cytokines in astrocytes and infection of 
astrocytes by both MAD78 and NY99 led to increased secretion of pro-inflammatory cytokines 
(Figure 3.9). In addition to the induction of apoptosis in NPCs by infection with WNV NY99, this 
could be an additional means by which WNV NY99 reduces the NPC population. 
 Cell cycle manipulation by DNA viruses that replicate in the nucleus of infected cells has 
been observed. These viruses utilize the host DNA-synthesis machinery to facilitate the replication 
of their DNA genomes. Several oncolytic viruses, such as human T-cell leukemia virus and human 
papilloma virus, encode proteins that directly interact with cyclin proteins to facilitate cell cycle 
entry into S-phase (Nascimento, Costa et al. 2012). Herpesviruses encode cyclin mimics that can 
interact with the host cell cycle regulatory proteins (Nascimento, Costa et al. 2012). RNA viruses 
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have also been shown to modulate the cell cycle although the reason for doing so remains unclear. 
Infectious bronchitis virus infection arrests Vero cells in the G2/M phase and produced increased 
viral yields in synchronized cells (Dove, Brooks et al. 2006). Chronic infection with Hepatits C 
virus (HCV) induces G1 phase arrest in hepatocytes and this may be a major contributor to HCV-
related cirrhosis (Marshall, Rushbrook et al. 2005). Infection of human NPCs with ZIKV or DENV 
decreased the expression of cell cycle progression genes (Zhang, Hammack et al. 2016). In the 
current study, NPCs infected with WNV NY99 had decreased expression of cell cycle and mitosis 
genes and showed decreased cell proliferation compared to mock infected cells (Figure 3.7G & 
Figure 3.9B). In SNB-19 cells, S-phase arrest by treatment with thymidine had a positive effect on 
WNV translation and genome RNA production (Figure 3.11B, C). Interestingly, treatment of SNB-
19 cells with aphidicolin, which causes cell cycle arrest at the G1/S interface, did not appear to 
have a significant impact on NY99 replication (Figure 3.11B, C). The advantage of cell cycle 
perturbations for the replication cycles NY99 and other flaviviruses are not known. 
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4 CONCLUSIONS AND FUTURE DIRECTIONS 
Characterization of components of flavivirus disease resistance in mice 
 The life cycle of RNA viruses occurs entirely in the cytoplasm of the host cell it infects 
and interactions with host factors in the cell are major determinants of the outcome of infections 
with RNA viruses. Mice express a single gene, Oas1b, which conveys resistance to all members 
of the genus Flavivirus (Scherbik, Kluetzman et al. 2007). The finding that a single host gene can 
have such broad antiviral activity means it is targeting a critical component that is unique to the 
flavivirus life cycle. Work described in this dissertation and in previous studies (Scherbik, 
Paranjape et al. 2006, Elbahesh, Jha et al. 2011) all indicate that Oas1b does not exert its anti-
flavivirus activity through activation of RNase L.  
 Mice expressing the resistant form of Oas1b produce decreased levels of viral RNA and 
infectious virus. In the present study, this was observed both by direct observation of dsRNA 
staining in infected brains and by measurement of viral plus strand RNA by qRT-PCR. The full 
length, resistant form of Oas1b has a transmembrane domain that targets it to the ER membrane in 
cells (Courtney, Di et al. 2012). Since flavivirus replication is associated with the ER membrane, 
localization of Oas1b to the viral replication complex vesicles in the ER membrane of infected 
cells is likely an important component of its anti-flavivirus activity. Future experiments should 
seek to determine if Oas1b and its binding partners are located inside viral replication vesicles in 
infected cells. Detection of a recombinant V5-tagged Oas1b protein that is expressed from an 
oas1b mRNA together with detection of dsRNA with anti-dsRNA antibody by high resolution 
imaging techniques, such as dSTORM imaging, in infected cells could be used to probe the 
colocalization of Oas1b and viral replication vesicles. Additionally, the interior of the replication 
complexes could be probed after ultracentrifugation to separate membranous components of the 
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cell into discrete fractions by immunoblotting. This approach has been used with YFV infected 
cells to determine the role of the host protein DNAJC14 in viral replication vesicle formation (Yi, 
Yuan et al. 2012). 
 The role that Oas1b plays in inhibiting viral (+)RNA production will require additional 
analysis. The most likely mechanism is through interaction with or effects on the functions of viral 
nonstructural proteins in the viral replication complex. Serial passage of WNV in cells expressing 
Oas1b yielded a virus mutant that had improved RNA production in resistant cells. The mutations 
were located in the NS3 helicase domain and in the NS4A gene C-terminal 2K domain (Mertens, 
Kajaste-Rudnitski et al. 2010). The flavivirus NS3 protein is found in the replication vesicles of 
infected cells and hydrolyzes ATP as part of its helicase function that unwinds the viral dsRNA 
and facilitates the synthesis of nascent genome RNA. NS4A is a cofactor for helicase activity but 
not for ATPase activity (Shiryaev, Chernov et al. 2009). An in vitro study of DENV NS3 activity 
showed that when the ATP concentration is low, NS3 switches from dsRNA unwinding to RNA 
strand annealing  (Gebhard, Kaufman et al. 2012). The presence of Oas1b and its binding partner 
ABCF3, which both contain ATP-binding and ATPase domains, in the replication vesicles of 
resistant infected cells could decrease the effective concentration of ATP available for NS3 and 
result in inefficient dsRNA unwinding. 
 Infected brains from resistant mice showed decreased amplification of dsRNA staining 
compared to susceptible mice at later times post infection even though the dsRNA staining patterns 
were comparable in the brains of resistant and susceptible mice at early times after infection. The 
observed amplification of the area and intensity of the dsRNA signal in susceptible infected cells 
could be due to an increase in the size of the individual replication vesicles or an increase in the 
number of vesicles. Expression of recombinant WNV NS4A-2K protein alone can induce ER 
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membrane rearrangement in infected cells (Roosendaal, Westaway et al. 2006). The possibility of 
an interaction between viral NS4A-2K with Oas1b and its binding partners that decreases the 
formation of additional replication vesicles should be investigated. 
 Modulation of lipid homeostasis in infected cells is critical for efficient flavivirus 
replication, which is dependent on the proliferation and modification of cell cytoplasmic 
membranes. The lipid profile of the ER membrane in host cells is dramatically altered during 
infection with flaviviruses. Cholesterol is particularly important to facilitate membrane bending 
for vesicle formation (Martin-Acebes, Vazquez-Calvo et al. 2016). Flavivirus infection enhances 
cholesterol biosynthesis in infected cells and reroutes cellular cholesterol to viral replication 
vesicles in the ER membrane (Mackenzie, Khromykh et al. 2007). The Oas1b binding partner 
Orp1L has a cholesterol sensing domain and functions in the endosomal pathway to transfer late 
endosome-associated cholesterol to the ER membrane (Courtney, Di et al. 2012, Zhao and 
Ridgway 2017). Oas1b interaction with Orp1L during virus infection may inhibit this activity, 
resulting in inefficient ER membrane rearrangement by the virus and loss of replication vesicle 
formation. Further studies of the involvement of Orp1L in the resistance phenotype are needed. 
 
Characterization of the response of human pluripotent stem cell-derived CNS cells to 
infection with avirulent and virulent strains of WNV 
 WNV NY99 efficiently infects human NPCs, astrocytes, PMNs and MNs (Figure 3.1 & 
3.2). This broadly covers all of the major cell types of the CNS as being permissive to infection 
by NY99. In developing fetuses, NPCs differentiate into radial glial cells that then differentiate 
into glial cell subtypes, such as astrocytes, or into different neuronal subtypes, such as Purkinje 
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cells or motor neurons (Lui, Hansen et al. 2011). Neuronal subtypes in mice have shown variation 
in their baseline expression levels of ISGs that influence susceptibility to infection by RNA viruses 
(Cho, Proll et al. 2013). The degree of susceptibility of different human neuronal subtypes to WNV 
infection warrants further investigation. There are protocols currently being developed to 
differentiate hiPSC-derived cells into specific neuronal subtypes (Mukhtar and Taylor 2018). The 
recent development of human 3D neural organoids formed by self-assembly of stem cells provides 
a means of studying the virus susceptibility of different neuronal subtypes as they arise naturally 
during the growth of the organoid (Lancaster, Renner et al. 2013, Qian, 2016 #652).  
 There is emerging evidence of the role of cytokines in not only controlling inflammation 
in response to tissue injury or pathogen infection but also in dictating the differentiation of stem 
cells including NPCs. NPC-derived radial glial cells in the brain self-renew to maintain a pool of 
neural cell progenitors that can differentiate into neurons or astrocytes in response to Jak-STAT 
signaling (Deverman and Patterson 2009). In mice infected with WNV, IL-1 production by 
myeloid cells facilitated a switch in NPC differentiation from neurogenesis to astrogenesis in the 
hippocampus that may have contributed to cognitive deficits and memory loss (Garber, Vasek et 
al. 2018). Interestingly, transcriptome profiling of NPCs infected with WNV MAD78 and WNV 
NY99 in the present study indicated that infections with both viruses downregulated genes 
associated with neuron development in the absence of signaling from other cell types (Figure 3.7). 
Pro-inflammatory cytokine genes were also upregulated in infected NPCs. The extent of 
production of inflammatory cytokines by these cells needs to be determined to see if infected NPCs 
control their own differentiation in response to virus infection. Astrocytes infected with MAD78 
and NY99 secreted pro-inflammatory cytokines CXCL10, IL-6 and CCL5 (Figure 3.13). The 
effect of these cytokines on other neural cell types needs to be assessed.  
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 Caspase-3-dependent cell death has been implicated as the major contributor to neuronal 
death in mice infected with WNV (Samuel, Morrey et al. 2007). Virulent and avirulent WNV 
strains differed in their ability to activate caspase-3 in mouse brains following infection and also 
differed in which brain regions apoptosis was observed (Donadieu, Lowenski et al. 2013). WNV 
NY99 infection of human neurons and NPCs induced caspase-3 cleavage (Figure 3.2A, B). 
Treatment of NPCs and neurons with the pan-caspase inhibitor emricasan blocked caspase-3 
activation by WNV NY99 infection (Figure 3.2E, F). Interestingly, the levels of infectious virus 
produced in neurons treated with emricasan did not decrease at later times post infection while the 
levels in untreated neurons decreased. This prolonged production of virus in caspase-inhibited 
cells suggests the possibility that persistent infections of these cells by WNV NY99 could be 
established. Persistent WNV infection in the spinal cords of mice was previously observed 
(Appler, Brown et al. 2010). A single case study of an immunocompetent patient indicated that 
persistent infection by WNV in humans is possible (Penn, Guarner et al. 2006). Also, the non-
pathogenic WNV MAD78 did not cause significant cleavage of caspase-3 in infected human NPCs 
despite efficiently replicating in these cells, suggesting the possibility of a persisting infection with 
this WNV strain in NPCs (Figure 3.5C). Future studies should determine the ability of WNV 
MAD78 and WNV NY99 to cause persistent infection in CNS cells. 
 
 
 
 
85 
5 REFERENCES 
Ackermann, M. and R. Padmanabhan (2001). "De novo synthesis of RNA by the dengue virus 
RNA-dependent RNA polymerase exhibits temperature dependence at the initiation but not 
elongation phase." J Biol Chem 276(43): 39926-39937. 
Appler, K. K., A. N. Brown, B. S. Stewart, M. J. Behr, V. L. Demarest, S. J. Wong and K. A. 
Bernard (2010). "Persistence of West Nile virus in the central nervous system and periphery of 
mice." PLoS One 5(5): e10649. 
Armah, H. B., G. Wang, B. I. Omalu, R. B. Tesh, K. A. Gyure, D. J. Chute, R. D. Smith, P. Dulai, 
H. V. Vinters, B. K. Kleinschmidt-DeMasters and C. A. Wiley (2007). "Systemic distribution of 
West Nile virus infection: postmortem immunohistochemical study of six cases." Brain Pathol 
17(4): 354-362. 
Baranovskiy, A. G., N. D. Babayeva, Y. Suwa, J. Gu, Y. I. Pavlov and T. H. Tahirov (2014). 
"Structural basis for inhibition of DNA replication by aphidicolin." Nucleic Acids Res 42(22): 
14013-14021. 
Beasley, D. W., L. Li, M. T. Suderman and A. D. Barrett (2002). "Mouse neuroinvasive phenotype 
of West Nile virus strains varies depending upon virus genotype." Virology 296(1): 17-23. 
Benarroch, D., B. Selisko, G. A. Locatelli, G. Maga, J. L. Romette and B. Canard (2004). "The 
RNA helicase, nucleotide 5'-triphosphatase, and RNA 5'-triphosphatase activities of Dengue virus 
protein NS3 are Mg2+-dependent and require a functional Walker B motif in the helicase catalytic 
core." Virology 328(2): 208-218. 
Best, S. M., K. L. Morris, J. G. Shannon, S. J. Robertson, D. N. Mitzel, G. S. Park, E. Boer, J. B. 
Wolfinbarger and M. E. Bloom (2005). "Inhibition of interferon-stimulated JAK-STAT signaling 
by a tick-borne flavivirus and identification of NS5 as an interferon antagonist." J Virol 79(20): 
12828-12839. 
Blazquez, A. B., E. Escribano-Romero, T. Merino-Ramos, J. C. Saiz and M. A. Martin-Acebes 
(2014). "Stress responses in flavivirus-infected cells: activation of unfolded protein response and 
autophagy." Front Microbiol 5: 266. 
Bond, A. M., G. L. Ming and H. Song (2015). "Adult Mammalian Neural Stem Cells and 
Neurogenesis: Five Decades Later." Cell Stem Cell 17(4): 385-395. 
Brinton, M. A. (2014). "Replication cycle and molecular biology of the West Nile virus." Viruses 
6(1): 13-53. 
Brinton, M. A., H. Arnheiter and O. Haller (1982). "Interferon independence of genetically 
controlled resistance to flaviviruses." Infect Immun 36(1): 284-288. 
Brinton, M. A. and A. A. Perelygin (2003). "Genetic resistance to flaviviruses." Adv Virus Res 
60: 43-85. 
Burakoff, A., J. Lehman, M. Fischer, J. E. Staples and N. P. Lindsey (2018). "West Nile Virus and 
Other Nationally Notifiable Arboviral Diseases - United States, 2016." MMWR Morb Mortal 
Wkly Rep 67(1): 13-17. 
Centers for Disease, C. and Prevention (2013). "West Nile virus and other arboviral diseases--
United States, 2012." MMWR Morb Mortal Wkly Rep 62(25): 513-517. 
Cheeran, M. C., S. Hu, W. S. Sheng, A. Rashid, P. K. Peterson and J. R. Lokensgard (2005). 
"Differential responses of human brain cells to West Nile virus infection." J Neurovirol 11(6): 512-
524. 
Chen, S., Z. Wu, M. Wang and A. Cheng (2017). "Innate Immune Evasion Mediated by 
Flaviviridae Non-Structural Proteins." Viruses 9(10). 
86 
Cho, H. and M. S. Diamond (2012). "Immune responses to West Nile virus infection in the central 
nervous system." Viruses 4(12): 3812-3830. 
Cho, H., S. C. Proll, K. J. Szretter, M. G. Katze, M. Gale, Jr. and M. S. Diamond (2013). 
"Differential innate immune response programs in neuronal subtypes determine susceptibility to 
infection in the brain by positive-stranded RNA viruses." Nat Med 19(4): 458-464. 
Choi, S. S., H. J. Lee, I. Lim, J.-i. Satoh and S. U. Kim (2014). "Human Astrocytes: Secretome 
Profiles of Cytokines and Chemokines." PLOS ONE 9(4): e92325. 
Clarke, P., J. S. Leser, E. D. Quick, K. R. Dionne, J. D. Beckham and K. L. Tyler (2014). "Death 
receptor-mediated apoptotic signaling is activated in the brain following infection with West Nile 
virus in the absence of a peripheral immune response." J Virol 88(2): 1080-1089. 
Courtney, S. C., H. Di, B. M. Stockman, H. Liu, S. V. Scherbik and M. A. Brinton (2012). 
"Identification of novel host cell binding partners of Oas1b, the protein conferring resistance to 
flavivirus-induced disease in mice." J Virol 86(15): 7953-7963. 
Cumberworth, S. L., J. J. Clark, A. Kohl and C. L. Donald (2017). "Inhibition of type I interferon 
induction and signalling by mosquito-borne flaviviruses." Cell Microbiol 19(5). 
Cuylen, S., C. Blaukopf, A. Z. Politi, T. Muller-Reichert, B. Neumann, I. Poser, J. Ellenberg, A. 
A. Hyman and D. W. Gerlich (2016). "Ki-67 acts as a biological surfactant to disperse mitotic 
chromosomes." Nature 535(7611): 308-312. 
Daneman, R. and A. Prat (2015). "The blood-brain barrier." Cold Spring Harb Perspect Biol 7(1): 
a020412. 
Deegan, T. D. and J. F. Diffley (2016). "MCM: one ring to rule them all." Curr Opin Struct Biol 
37: 145-151. 
Deo, S., T. R. Patel, G. Chojnowski, A. Koul, E. Dzananovic, K. McEleney, J. M. Bujnicki and S. 
A. McKenna (2015). "Characterization of the termini of the West Nile virus genome and their 
interactions with the small isoform of the 2' 5'-oligoadenylate synthetase family." J Struct Biol 
190(2): 236-249. 
Deverman, B. E. and P. H. Patterson (2009). "Cytokines and CNS development." Neuron 64(1): 
61-78. 
Diniz, J. A., A. P. Da Rosa, H. Guzman, F. Xu, S. Y. Xiao, V. L. Popov, P. F. Vasconcelos and R. 
B. Tesh (2006). "West Nile virus infection of primary mouse neuronal and neuroglial cells: the 
role of astrocytes in chronic infection." Am J Trop Med Hyg 75(4): 691-696. 
Donadieu, E., S. Lowenski, J. L. Servely, E. Laloy, T. Lilin, N. Nowotny, J. Richardson, S. 
Zientara, S. Lecollinet and M. Coulpier (2013). "Comparison of the neuropathology induced by 
two West Nile virus strains." PLoS One 8(12): e84473. 
Donovan, J., M. Dufner and A. Korennykh (2013). "Structural basis for cytosolic double-stranded 
RNA surveillance by human oligoadenylate synthetase 1." Proc Natl Acad Sci U S A 110(5): 1652-
1657. 
Dove, B., G. Brooks, K. Bicknell, T. Wurm and J. A. Hiscox (2006). "Cell cycle perturbations 
induced by infection with the coronavirus infectious bronchitis virus and their effect on virus 
replication." J Virol 80(8): 4147-4156. 
Edgil, D., M. S. Diamond, K. L. Holden, S. M. Paranjape and E. Harris (2003). "Translation 
efficiency determines differences in cellular infection among dengue virus type 2 strains." 
Virology 317(2): 275-290. 
Edgil, D., C. Polacek and E. Harris (2006). "Dengue virus utilizes a novel strategy for translation 
initiation when cap-dependent translation is inhibited." J Virol 80(6): 2976-2986. 
87 
Elbahesh, H., B. K. Jha, R. H. Silverman, S. V. Scherbik and M. A. Brinton (2011). "The Flvr-
encoded murine oligoadenylate synthetase 1b (Oas1b) suppresses 2-5A synthesis in intact cells." 
Virology 409(2): 262-270. 
Elkhateeb, E., H. T. Tag-El-Din-Hassan, N. Sasaki, D. Torigoe, M. Morimatsu and T. Agui (2016). 
"The role of mouse 2',5'-oligoadenylate synthetase 1 paralogs." Infect Genet Evol 45: 393-401. 
Erbel, P., N. Schiering, A. D'Arcy, M. Renatus, M. Kroemer, S. P. Lim, Z. Yin, T. H. Keller, S. 
G. Vasudevan and U. Hommel (2006). "Structural basis for the activation of flaviviral NS3 
proteases from dengue and West Nile virus." Nat Struct Mol Biol 13(4): 372-373. 
Erdelyi, K., K. Ursu, E. Ferenczi, L. Szeredi, F. Ratz, J. Skare and T. Bakonyi (2007). "Clinical 
and pathologic features of lineage 2 West Nile virus infections in birds of prey in Hungary." Vector 
Borne Zoonotic Dis 7(2): 181-188. 
Garber, C., M. J. Vasek, L. L. Vollmer, T. Sun, X. Jiang and R. S. Klein (2018). "Astrocytes 
decrease adult neurogenesis during virus-induced memory dysfunction via IL-1." Nat Immunol 
19(2): 151-161. 
Gebhard, L. G., S. B. Kaufman and A. V. Gamarnik (2012). "Novel ATP-independent RNA 
annealing activity of the dengue virus NS3 helicase." PLoS One 7(4): e36244. 
Gotz, M. and W. B. Huttner (2005). "The cell biology of neurogenesis." Nat Rev Mol Cell Biol 
6(10): 777-788. 
Guyatt, K. J., E. G. Westaway and A. A. Khromykh (2001). "Expression and purification of 
enzymatically active recombinant RNA-dependent RNA polymerase (NS5) of the flavivirus 
Kunjin." J Virol Methods 92(1): 37-44. 
Hou, S., A. Kumar, Z. Xu, A. M. Airo, I. Stryapunina, C. P. Wong, W. Branton, E. Tchesnokov, 
M. Gotte, C. Power and T. C. Hobman (2017). "Zika virus hijacks stress granule proteins and 
modulates the host stress response." J Virol. 
Huang da, W., B. T. Sherman and R. A. Lempicki (2009). "Systematic and integrative analysis of 
large gene lists using DAVID bioinformatics resources." Nat Protoc 4(1): 44-57. 
Hussmann, K. L., M. A. Samuel, K. S. Kim, M. S. Diamond and B. L. Fredericksen (2013). 
"Differential replication of pathogenic and nonpathogenic strains of West Nile virus within 
astrocytes." J Virol 87(5): 2814-2822. 
Hussmann, K. L., R. Vandergaast, K. Zheng, L. I. Hoover and B. L. Fredericksen (2014). 
"Structural proteins of West Nile virus are a major determinant of infectious particle production 
and fitness in astrocytes." J Gen Virol 95(Pt 9): 1991-2003. 
Iranpour, M., A. R. Moghadam, M. Yazdi, S. R. Ande, J. Alizadeh, E. Wiechec, R. Lindsay, M. 
Drebot, K. M. Coombs and S. Ghavami (2016). "Apoptosis, autophagy and unfolded protein 
response pathways in Arbovirus replication and pathogenesis." Expert Rev Mol Med 18: e1. 
Johnston, L. J., G. M. Halliday and N. J. King (2000). "Langerhans cells migrate to local lymph 
nodes following cutaneous infection with an arbovirus." J Invest Dermatol 114(3): 560-568. 
Kadri, H., O. A. Lambourne and Y. Mehellou (2018). "Niclosamide, a drug with many 
(re)purposes." ChemMedChem. 
Kakuta, S., S. Shibata and Y. Iwakura (2002). "Genomic structure of the mouse 2',5'-
oligoadenylate synthetase gene family." J Interferon Cytokine Res 22(9): 981-993. 
Kawai, T. and S. Akira (2007). "Antiviral signaling through pattern recognition receptors." J 
Biochem 141(2): 137-145. 
Keller, B. C., B. L. Fredericksen, M. A. Samuel, R. E. Mock, P. W. Mason, M. S. Diamond and 
M. Gale, Jr. (2006). "Resistance to alpha/beta interferon is a determinant of West Nile virus 
replication fitness and virulence." J Virol 80(19): 9424-9434. 
88 
Khromykh, A. A., H. Meka, K. J. Guyatt and E. G. Westaway (2001). "Essential role of cyclization 
sequences in flavivirus RNA replication." J Virol 75(14): 6719-6728. 
Khromykh, A. A., P. L. Sedlak, K. J. Guyatt, R. A. Hall and E. G. Westaway (1999). "Efficient 
trans-complementation of the flavivirus kunjin NS5 protein but not of the NS1 protein requires its 
coexpression with other components of the viral replicase." J Virol 73(12): 10272-10280. 
Lancaster, M. A., M. Renner, C. A. Martin, D. Wenzel, L. S. Bicknell, M. E. Hurles, T. Homfray, 
J. M. Penninger, A. P. Jackson and J. A. Knoblich (2013). "Cerebral organoids model human brain 
development and microcephaly." Nature 501(7467): 373-379. 
Lanciotti, R. S., G. D. Ebel, V. Deubel, A. J. Kerst, S. Murri, R. Meyer, M. Bowen, N. McKinney, 
W. E. Morrill, M. B. Crabtree, L. D. Kramer and J. T. Roehrig (2002). "Complete genome 
sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, 
Europe, and the Middle East." Virology 298(1): 96-105. 
Lee, Y. R., S. H. Kuo, C. Y. Lin, P. J. Fu, Y. S. Lin, T. M. Yeh and H. S. Liu (2018). "Dengue 
virus-induced ER stress is required for autophagy activation, viral replication, and pathogenesis 
both in vitro and in vivo." Sci Rep 8(1): 489. 
Lindenbach, B. D., C. L. Murray, H. J. Thiel and C. M. Rice (2013). Flaviviridae, Specific virus 
families, Fields Virology 
Philadelphia, PA, Wolters Kluwer/Lippincott Williams & Wilkins Health. 
Lo, M. K., M. Tilgner, K. A. Bernard and P. Y. Shi (2003). "Functional analysis of mosquito-
borne flavivirus conserved sequence elements within 3' untranslated region of West Nile virus by 
use of a reporting replicon that differentiates between viral translation and RNA replication." J 
Virol 77(18): 10004-10014. 
Loo, Y. M., J. Fornek, N. Crochet, G. Bajwa, O. Perwitasari, L. Martinez-Sobrido, S. Akira, M. 
A. Gill, A. Garcia-Sastre, M. G. Katze and M. Gale, Jr. (2008). "Distinct RIG-I and MDA5 
signaling by RNA viruses in innate immunity." J Virol 82(1): 335-345. 
Lui, J. H., D. V. Hansen and A. R. Kriegstein (2011). "Development and evolution of the human 
neocortex." Cell 146(1): 18-36. 
Mackenzie, J. M., A. A. Khromykh and R. G. Parton (2007). "Cholesterol manipulation by West 
Nile virus perturbs the cellular immune response." Cell Host Microbe 2(4): 229-239. 
Marlowe, J. L. and A. Puga (2005). "Aryl hydrocarbon receptor, cell cycle regulation, toxicity, 
and tumorigenesis." J Cell Biochem 96(6): 1174-1184. 
Marshall, A., S. Rushbrook, S. E. Davies, L. S. Morris, I. S. Scott, S. L. Vowler, N. Coleman and 
G. Alexander (2005). "Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and 
fibrosis in chronic hepatitis C virus infection." Gastroenterology 128(1): 33-42. 
Martin-Acebes, M. A., A. Vazquez-Calvo and J. C. Saiz (2016). "Lipids and flaviviruses, present 
and future perspectives for the control of dengue, Zika, and West Nile viruses." Prog Lipid Res 
64: 123-137. 
Medigeshi, G. R., A. M. Lancaster, A. J. Hirsch, T. Briese, W. I. Lipkin, V. Defilippis, K. Fruh, 
P. W. Mason, J. Nikolich-Zugich and J. A. Nelson (2007). "West Nile virus infection activates the 
unfolded protein response, leading to CHOP induction and apoptosis." J Virol 81(20): 10849-
10860. 
Melian, E. B., J. H. Edmonds, T. K. Nagasaki, E. Hinzman, N. Floden and A. A. Khromykh (2013). 
"West Nile virus NS2A protein facilitates virus-induced apoptosis independently of interferon 
response." J Gen Virol 94(Pt 2): 308-313. 
Mertens, E., A. Kajaste-Rudnitski, S. Torres, A. Funk, M. P. Frenkiel, I. Iteman, A. A. Khromykh 
and P. Despres (2010). "Viral determinants in the NS3 helicase and 2K peptide that promote West 
89 
Nile virus resistance to antiviral action of 2',5'-oligoadenylate synthetase 1b." Virology 399(1): 
176-185. 
Mogk, A., B. Bukau and H. H. Kampinga (2018). "Cellular Handling of Protein Aggregates by 
Disaggregation Machines." Mol Cell 69(2): 214-226. 
Mukherjee, S., N. Singh, N. Sengupta, M. Fatima, P. Seth, A. Mahadevan, S. K. Shankar, A. 
Bhattacharyya and A. Basu (2017). "Japanese encephalitis virus induces human neural 
stem/progenitor cell death by elevating GRP78, PHB and hnRNPC through ER stress." Cell Death 
Dis 8(1): e2556. 
Mukhopadhyay, S., R. J. Kuhn and M. G. Rossmann (2005). "A structural perspective of the 
flavivirus life cycle." Nat Rev Microbiol 3(1): 13-22. 
Mukhtar, T. and V. Taylor (2018). "Untangling Cortical Complexity During Development." J Exp 
Neurosci 12: 1179069518759332. 
Nascimento, R., H. Costa and R. M. Parkhouse (2012). "Virus manipulation of cell cycle." 
Protoplasma 249(3): 519-528. 
Penn, R. G., J. Guarner, J. J. Sejvar, H. Hartman, R. D. McComb, D. L. Nevins, J. Bhatnagar and 
S. R. Zaki (2006). "Persistent neuroinvasive West Nile virus infection in an immunocompromised 
patient." Clin Infect Dis 42(5): 680-683. 
Perelygin, A. A., S. V. Scherbik, I. B. Zhulin, B. M. Stockman, Y. Li and M. A. Brinton (2002). 
"Positional cloning of the murine flavivirus resistance gene." Proc Natl Acad Sci U S A 99(14): 
9322-9327. 
Perez Dominguez, M., R. Rojas, E. Bandeira, D. Requena, A. C. Ferreras, J. L. Triana and F. 
Triana-Alonso (2015). "[5 cap -independent translation of dengue virus genomic RNA]." Rev Peru 
Med Exp Salud Publica 32(1): 11-18. 
Polacek, C., P. Friebe and E. Harris (2009). "Poly(A)-binding protein binds to the non-
polyadenylated 3' untranslated region of dengue virus and modulates translation efficiency." J Gen 
Virol 90(Pt 3): 687-692. 
Pryor, M. J., S. M. Rawlinson, R. E. Butcher, C. L. Barton, T. A. Waterhouse, S. G. Vasudevan, 
P. G. Bardin, P. J. Wright, D. A. Jans and A. D. Davidson (2007). "Nuclear localization of dengue 
virus nonstructural protein 5 through its importin alpha/beta-recognized nuclear localization 
sequences is integral to viral infection." Traffic 8(7): 795-807. 
Quick, E. D., J. S. Leser, P. Clarke and K. L. Tyler (2014). "Activation of intrinsic immune 
responses and microglial phagocytosis in an ex vivo spinal cord slice culture model of West Nile 
virus infection." J Virol 88(22): 13005-13014. 
Rocha, N., C. Kuijl, R. van der Kant, L. Janssen, D. Houben, H. Janssen, W. Zwart and J. Neefjes 
(2009). "Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-RILP-p150 
Glued and late endosome positioning." J Cell Biol 185(7): 1209-1225. 
Roosendaal, J., E. G. Westaway, A. Khromykh and J. M. Mackenzie (2006). "Regulated cleavages 
at the West Nile virus NS4A-2K-NS4B junctions play a major role in rearranging cytoplasmic 
membranes and Golgi trafficking of the NS4A protein." J Virol 80(9): 4623-4632. 
Sadek, J. R., S. A. Pergam, J. A. Harrington, L. A. Echevarria, L. E. Davis, D. Goade, J. Harnar, 
R. A. Nofchissey, C. M. Sewell, P. Ettestad and K. Y. Haaland (2010). "Persistent 
neuropsychological impairment associated with West Nile virus infection." J Clin Exp 
Neuropsychol 32(1): 81-87. 
Samuel, M. A. and M. S. Diamond (2005). "Alpha/beta interferon protects against lethal West Nile 
virus infection by restricting cellular tropism and enhancing neuronal survival." J Virol 79(21): 
13350-13361. 
90 
Samuel, M. A. and M. S. Diamond (2009). West Nile Virus Infection of the Central Nervous 
System. West Nile Encephalitis Virus Infection Virla pathogenesis and the host immune response. 
M. S. Diamond. New York, NY, Springer: 379-299. 
Samuel, M. A., J. D. Morrey and M. S. Diamond (2007). "Caspase 3-dependent cell death of 
neurons contributes to the pathogenesis of West Nile virus encephalitis." Journal of Virology 
81(6): 2614-2623. 
Samuel, M. A., J. D. Morrey and M. S. Diamond (2007). "Caspase 3-dependent cell death of 
neurons contributes to the pathogenesis of West Nile virus encephalitis." J Virol 81(6): 2614-2623. 
Samuel, M. A., K. Whitby, B. C. Keller, A. Marri, W. Barchet, B. R. Williams, R. H. Silverman, 
M. Gale, Jr. and M. S. Diamond (2006). "PKR and RNase L contribute to protection against lethal 
West Nile Virus infection by controlling early viral spread in the periphery and replication in 
neurons." J Virol 80(14): 7009-7019. 
Scherbik, S. V., K. Kluetzman, A. A. Perelygin and M. A. Brinton (2007). "Knock-in of the 
Oas1b(r) allele into a flavivirus-induced disease susceptible mouse generates the resistant 
phenotype." Virology 368(2): 232-237. 
Scherbik, S. V., J. M. Paranjape, B. M. Stockman, R. H. Silverman and M. A. Brinton (2006). 
"RNase L plays a role in the antiviral response to West Nile virus." J Virol 80(6): 2987-2999. 
Schriml, L. M. and M. Dean (2000). "Identification of 18 mouse ABC genes and characterization 
of the ABC superfamily in Mus musculus." Genomics 64(1): 24-31. 
Shellam, G. R., M. Y. Sangster and N. Urosevic (1998). "Genetic control of host resistance to 
flavivirus infection in animals." Rev Sci Tech 17(1): 231-248. 
Shiryaev, S. A., A. V. Chernov, A. E. Aleshin, T. N. Shiryaeva and A. Y. Strongin (2009). "NS4A 
regulates the ATPase activity of the NS3 helicase: a novel cofactor role of the non-structural 
protein NS4A from West Nile virus." J Gen Virol 90(Pt 9): 2081-2085. 
Shives, K. D., K. L. Tyler and J. D. Beckham (2017). "Molecular mechanisms of 
neuroinflammation and injury during acute viral encephalitis." J Neuroimmunol 308: 102-111. 
Silverman, R. H. (2007). "Viral encounters with 2',5'-oligoadenylate synthetase and RNase L 
during the interferon antiviral response." J Virol 81(23): 12720-12729. 
Sumida, Y. and M. Yoneda (2017). "Current and future pharmacological therapies for 
NAFLD/NASH." J Gastroenterol. 
Suthar, M. S., S. Aguirre and A. Fernandez-Sesma (2013). "Innate immune sensing of 
flaviviruses." PLoS Pathog 9(9): e1003541. 
Suthar, M. S., M. S. Diamond and M. Gale, Jr. (2013). "West Nile virus infection and immunity." 
Nat Rev Microbiol 11(2): 115-128. 
Taguwa, S., K. Maringer, X. Li, D. Bernal-Rubio, J. N. Rauch, J. E. Gestwicki, R. Andino, A. 
Fernandez-Sesma and J. Frydman (2015). "Defining Hsp70 Subnetworks in Dengue Virus 
Replication Reveals Key Vulnerability in Flavivirus Infection." Cell 163(5): 1108-1123. 
Tang, H., C. Hammack, S. C. Ogden, Z. Wen, X. Qian, Y. Li, B. Yao, J. Shin, F. Zhang, E. M. 
Lee, K. M. Christian, R. A. Didier, P. Jin, H. Song and G. L. Ming (2016). "Zika Virus Infects 
Human Cortical Neural Progenitors and Attenuates Their Growth." Cell Stem Cell 18(5): 587-590. 
Urosevic, N., M. van Maanen, J. P. Mansfield, J. S. Mackenzie and G. R. Shellam (1997). 
"Molecular characterization of virus-specific RNA produced in the brains of flavivirus-susceptible 
and -resistant mice after challenge with Murray Valley encephalitis virus." J Gen Virol 78 ( Pt 1): 
23-29. 
van Marle, G., J. Antony, H. Ostermann, C. Dunham, T. Hunt, W. Halliday, F. Maingat, M. D. 
Urbanowski, T. Hobman, J. Peeling and C. Power (2007). "West Nile virus-induced 
91 
neuroinflammation: glial infection and capsid protein-mediated neurovirulence." J Virol 81(20): 
10933-10949. 
Villas-Boas, C. S., T. M. Conceicao, J. Ramirez, A. B. Santoro, A. T. Da Poian and M. Montero-
Lomeli (2009). "Dengue virus-induced regulation of the host cell translational machinery." Braz J 
Med Biol Res 42(11): 1020-1026. 
Wang, R. Y., Y. R. Huang, K. M. Chong, C. Y. Hung, Z. L. Ke and R. Y. Chang (2011). "DnaJ 
homolog Hdj2 facilitates Japanese encephalitis virus replication." Virol J 8: 471. 
Wang, T., T. Town, L. Alexopoulou, J. F. Anderson, E. Fikrig and R. A. Flavell (2004). "Toll-like 
receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis." Nat Med 
10(12): 1366-1373. 
Warde-Farley, D., S. L. Donaldson, O. Comes, K. Zuberi, R. Badrawi, P. Chao, M. Franz, C. 
Grouios, F. Kazi, C. T. Lopes, A. Maitland, S. Mostafavi, J. Montojo, Q. Shao, G. Wright, G. D. 
Bader and Q. Morris (2010). "The GeneMANIA prediction server: biological network integration 
for gene prioritization and predicting gene function." Nucleic Acids Res 38(Web Server issue): 
W214-220. 
Welsch, S., S. Miller, I. Romero-Brey, A. Merz, C. K. Bleck, P. Walther, S. D. Fuller, C. Antony, 
J. Krijnse-Locker and R. Bartenschlager (2009). "Composition and three-dimensional architecture 
of the dengue virus replication and assembly sites." Cell Host Microbe 5(4): 365-375. 
Wen, Z., H. N. Nguyen, Z. Guo, M. A. Lalli, X. Wang, Y. Su, N. S. Kim, K. J. Yoon, J. Shin, C. 
Zhang, G. Makri, D. Nauen, H. Yu, E. Guzman, C. H. Chiang, N. Yoritomo, K. Kaibuchi, J. Zou, 
K. M. Christian, L. Cheng, C. A. Ross, R. L. Margolis, G. Chen, K. S. Kosik, H. Song and G. L. 
Ming (2014). "Synaptic dysregulation in a human iPS cell model of mental disorders." Nature 
515(7527): 414-418. 
Whiteman, M. C., L. Li, J. A. Wicker, R. M. Kinney, C. Huang, D. W. Beasley, K. M. Chung, M. 
S. Diamond, T. Solomon and A. D. Barrett (2010). "Development and characterization of non-
glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus." 
Vaccine 28(4): 1075-1083. 
Whitfield, M. L., L. K. George, G. D. Grant and C. M. Perou (2006). "Common markers of 
proliferation." Nat Rev Cancer 6(2): 99-106. 
Winkelmann, E. R., H. Luo and T. Wang (2016). "West Nile Virus Infection in the Central Nervous 
System." F1000Res 5. 
Xu, M., E. M. Lee, Z. Wen, Y. Cheng, W. K. Huang, X. Qian, J. Tcw, J. Kouznetsova, S. C. 
Ogden, C. Hammack, F. Jacob, H. N. Nguyen, M. Itkin, C. Hanna, P. Shinn, C. Allen, S. G. 
Michael, A. Simeonov, W. Huang, K. M. Christian, A. Goate, K. J. Brennand, R. Huang, M. Xia, 
G. L. Ming, W. Zheng, H. Song and H. Tang (2016). "Identification of small-molecule inhibitors 
of Zika virus infection and induced neural cell death via a drug repurposing screen." Nat Med 
22(10): 1101-1107. 
Ye, J., Z. Chen, Y. Li, Z. Zhao, W. He, A. Zohaib, Y. Song, C. Deng, B. Zhang, H. Chen and S. 
Cao (2017). "Japanese Encephalitis Virus NS5 Inhibits Type I Interferon (IFN) Production by 
Blocking the Nuclear Translocation of IFN Regulatory Factor 3 and NF-kappaB." J Virol 91(8). 
Yi, Z., Z. Yuan, C. M. Rice and M. R. MacDonald (2012). "Flavivirus replication complex 
assembly revealed by DNAJC14 functional mapping." J Virol 86(21): 11815-11832. 
Zarouchlioti, C., D. A. Parfitt, W. Li, L. M. Gittings and M. E. Cheetham (2018). "DNAJ Proteins 
in neurodegeneration: essential and protective factors." Philos Trans R Soc Lond B Biol Sci 
373(1738). 
92 
Zehender, G., C. Veo, E. Ebranati, V. Carta, F. Rovida, E. Percivalle, A. Moreno, D. Lelli, M. 
Calzolari, A. Lavazza, C. Chiapponi, L. Baioni, G. Capelli, S. Ravagnan, G. Da Rold, E. Lavezzo, 
G. Palù, F. Baldanti, L. Barzon and M. Galli (2017). "Reconstructing the recent West Nile virus 
lineage 2 epidemic in Europe and Italy using discrete and continuous phylogeography." PLOS 
ONE 12(7): e0179679. 
Zhang, F., C. Hammack, S. C. Ogden, Y. Cheng, E. M. Lee, Z. Wen, X. Qian, H. N. Nguyen, Y. 
Li, B. Yao, M. Xu, T. Xu, L. Chen, Z. Wang, H. Feng, W. K. Huang, K. J. Yoon, C. Shan, L. 
Huang, Z. Qin, K. M. Christian, P. Y. Shi, M. Xu, M. Xia, W. Zheng, H. Wu, H. Song, H. Tang, 
G. L. Ming and P. Jin (2016). "Molecular signatures associated with ZIKV exposure in human 
cortical neural progenitors." Nucleic Acids Res 44(18): 8610-8620. 
Zhao, K. and N. D. Ridgway (2017). "Oxysterol-Binding Protein-Related Protein 1L Regulates 
Cholesterol Egress from the Endo-Lysosomal System." Cell Rep 19(9): 1807-1818. 
Zhou, A., J. Paranjape, T. L. Brown, H. Nie, S. Naik, B. Dong, A. Chang, B. Trapp, R. Fairchild, 
C. Colmenares and R. H. Silverman (1997). "Interferon action and apoptosis are defective in mice 
devoid of 2',5'-oligoadenylate-dependent RNase L." EMBO J 16(21): 6355-6363. 
 
